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ABSTRACT 
 
MODIFICATION OF PYRIMIDINE AND PURINE NUCLEOTIDES BY “CLICK” CHEMISTRY: 
DESIGN, SYNTHESIS AND PROPERTIES STUDY 
 
By 
 
Mohammad Mojibul Haque 
 
 
The University of Wisconsin-Milwaukee, 2014 
Under the Supervision of Professor Xiaohua Peng 
 
 
 
 
This dissertation consists of three main parts, totaling five chapters, and focuses on 
developing novel nucleosides via “click” chemistry and studying their potential biological 
iii 
 
properties. Chapter three describes the synthesis and properties of coumarin-modified 
fluorescent DNAs. Coumarin-modified 2’-deoxythymidine was synthesizedvia “click” 
chemistry and incorporated into oligodeoxynucleotides (ODNs) which induce 
photoreversible interstrand cross-link (ICL) upon 350/254 nm photoirradiation. The 
irradiation at 350 nminduces DNA cross-linking with ODNs containing coumarin. The 
cross-linked DNA products formed from coumarin are not fluorescent. Further 
investigation showed that coumarin moiety undergoes the (2π+2π) photocycloaddition 
with 2’-deoxythymidine (dT), 2’-deoxycytidine (dC), and to a much lower extent, 2’-
deoxyadenine (dA). As an additional ability, ICL materialwas observedto be reverted to 
their original single stranded ODN by a ring-opening reaction upon irradiation at 254 nm 
without the addition of any chemical reagents. After the successful discovery of the 
photo-reversible DNA cross-linking ability of coumarin-modified dT, coumarin was 
conjugated to dA and dC to examine the generality of this phenomina. This part is 
discussed in chapter four. In the fifth chapter, triazole- and phenyltriazole-modified dT 
were synthesized and incorporated into ODNs by solid phase DNA synthesis. Similar to 
the canonical nucleosides, the modified nucleoside scaffolds maintain Watson-Crick 
hydrogen bonding formation. Thephysic-chemical and biological properties of triazole-
containing ODN duplexes were investigated. 
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Chapter 1 
Introduction 
DNA is one of the most versatile molecules discovered to date. Current studies 
on the properties of modified DNAs showed that they led to many great discoveries in 
modern biological and medicinal field, such as new drug and biosensors discovery [1]. 
The DNA polymer consists of three components: (1) a pentose, (2) a nitrogenous base 
including purines and pyrimidines, and (3) a phosphodiester backbone (Figure 1). 
Modifications can be made to these three parts. The nitrogenous base moieties were 
selected in this research for modification with designed functional groups (Figure 1). 
 
Figure 1. The monomeric unit of DNA 
 
1.1 DNA Modification  
In natural DNA, the 2’-deoxynucleotides are distinguished by the four nitrogen 
bases: the purines adenine (A) and guanine (G), and the pyrimidines cytosine (C) and 
thymine (T). These four nucleobases show specific base recognition by forming Watson-
Crick base pair, namely A always pairing with T and C pairing with G (Figure 2). The 2’-
deoxynucleosides themselves are responsible for holding the DNA duplex together by 
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forming hydrogen bonding and π-π stacking. Hydrogen bonding interactions occur 
between complementary base pairs. dA forms a bidendate base pair with dT while dG 
forms a tridendate base pair with dC (Figure 2). The Watson-Crick base pair plays a 
critical role for the fidelity of DNA replication and transcription. Modification in the base 
moieties without affecting Watson-Crick base pair formation is highly important for 
maintaining their recognition property while also introducing new biological application. 
 
Figure 2. Complementary base pairs. dR= deoxyribose 
 
Modifying the nucleobases of 2’-deoxynucleosides with heterocyclic molecules 
are incredibly important for biological and medicinal chemistry, which is the main focus 
of this research. Heterocyclic molecules have UV absorption at longer wavelengths than 
the natural nucleobase moieties, which is important to introduce new photophysical 
properties. For example, indole and benzoxazole both have longer wavelengths of 
absorption and significantly higher quantum yields than their purine counterparts 
(Figure 3). Therefore 2’-deoxynucleosides were expected to show the significant 
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photophysical properties after processing with heterocyclic molecules and other 
functional groups.  
 
Figure 3 Comparison of wavelengths and quantum yields 
 
On behalf of modifying nucleotides and studying their photophysical properties, 
the following characteristics represent the desired attributes of newly designed 
nucleosides: (a) an emission band in the visible range, (b) a high structural similarity to 
the native nucleobases to mimic their size and shape, as well as hybridization and 
recognition properties, (c) the ability to form Watson-Crick base pairs and recognition 
properties and Hoogsteen face (a heteroatom at the position equivalent to the N7 
position of the purines) should preferably be present for purine analogs, (d) absorption 
spectrum with minimal overlap with the absorption spectrum of the natural bases, (e) a 
respectable emission quantum efficiency. 
In the past few decades, considerable advances have been made in the field of 
synthetically modified nucleosides and nucleotides depending on the type and nature of 
the functional group. The modification on nucleobase moieties plays a significant role 
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on several important cellular processes surrounding the DNA such as replication, 
transcription, and translation [2]. These modified nucleosides have been incorporated 
into oligodeoxynucleotides (ODNs). Several routes are potential for the modifications at 
the base unit of purine and pyrimidine including base substitution in which a designed 
functional group replaces the heterocycle of nucleoside analogs and extended base 
analogs in which a new functional group is attached through a linker to the heterocycle. 
Among those various processes, extending the conjugation of nucleotides with a 
naturally occurring heterocycle [3] has many valuable interactions and is an important 
tool for the study of the chemical reactivity and function of DNA and expanding its 
biological application.  
Nucleotides could be modified within the sugar moietis, phosphodiester 
backbone, and in the nucleobase in presynthetic modification. Altering at the 2' or 3' 
position of sugar unit is a viable option for the multipurpose study and these modified 
analogs are more closely mimic the behavior of their parent nucleotides than do 
pyrimidine and purine modified analogs.  Hiratsuka and Uchida were the first to 
introduce a sugar-modified nucleotide, 2',3'-O-2,4,6-trinitrocyclohexadienylidene, which 
exists as an equilibrium mixture depending on the pH of the solution [4]. Hiratsuka then 
introduced the 2',3'-O-anthraniloyl and 2',3'-O-methylanthraniloyl derivatives. 
In addition, base modification is also significant as it could be presynthetic and 
postsynthetic. Presyntheticmodification in base moieties has a wide variety of 
application such as DNA functionalization [5] and DNA methylation that involves the 
addition of a methyl group to different nucleotides by methyl transferase (MTase) [6]. 
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DNA methylation is essential for growth and development for gene expression in plants 
[7-10].  
 Modification at the 5-position of thymidineis is particularly important because it 
leads to distinctive application in nucleic acid. For example, 5-fluorouracil has been used 
for cancer treatment by inhibiting the synthesis of 2’-deoxythymidine because the 
carbon-fluorine bond is extremely stable and prevents the addition of a methyl group in 
the 5-position. The failure to synthesize the thymidine nucleotide results in little or no 
production of DNA. Another example of 5-position modification is phenylselenyl-
substituted derivatives of dT that produces interstrand cross-links in duplex DNA when 
oxidized by NaIO4 [11]. 
 
Scheme 1. Modification of ODN nucleotides at the 5-position of thymine. 
 
Based on these criteria, we sought to design and synthesize novel nucleosides 
where different functional groups or heterocycles are conjugated with nucleosides at 
the 5-position of pyrimidines or 6-position of purines, incorporate them into ODNs, and 
study their photophysical behavior within an oligomeric duplex.  
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1.2 Modified ODN Analogs 
Among the great varieties of heterocyclic molecules, coumarin, triazole, and 
phenyl-triazoleare are choosen to conjugate with 2’-deoxynucleosides (Scheme 2). 
Coumarins comprise a very large class of compounds among the plant kingdom [12-14], 
with a wide range of responses and sensitivie detection for cysteine (Cys) over 
homocysteine (Hcy) and glutathione (GSH) [15], unique photophysical, and 
spectroscopic properties. It has also been used quite effectively as a probe of the 
physical, structural, and chemical properties of a wide range of heterogeneous host 
systems. Another aspect of coumarin being chosen is that coumarin and its derivatives 
show sufficient fluorescence in the visible light range to be used in laser dyes and 
organic light-emitting diodes (LEDs) [16-20]. It shows fluorescence and phosphorescence 
spectra when irradiated at 320 nm. Researchers have studied the photophysics of 
coumarin compounds since the 1940s due in part to the tunability of their absorbance 
and fluorescence [21-28]. Fluorescence-based methods have become instrumental in 
advancing high throughput screening techniques, particularly in the context of drug 
discovery [29]. The ideal fluorophore would display, for example, the shifting 
wavelength of absorbance, emission, or excitation upon changes in its physical 
environment. 
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Scheme 2. Selected heterocyclic molecules for ODNmodification. 
 
Coumarin interaction in DNA is very much significant because coumarin-induced 
spectroscopic methods have been used to characterize the DNA and helps to analyze 
the information and their mechanisms in a very effective way when a coumarin-probe is 
incorporated into DNA at a specific site [30, 31]. For example, coumarin-modified 2’-
deoxynucleoside analogs are powerful tools for the investigation of nucleic acid 
structure if they are sensitive to their local environment, demonstrating changes in the 
fluorescent properties when induced by changes in polarity or pH. The applications of 
coumarin in the field of nucleic acid research are also significant.  The important 
applications are DNA detection [32], producing fluroscence-labelled DNA nucleosides 
[33], and functionalization of DNA with coumarin [34]. They maintain the hybridization 
properties of the parent nucleosides. In this research, coumarin and other heterocyclic 
groups are introduced to nucleobase analogs through a triazole linker (Scheme 3). 
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Scheme 3. Modified 2’-deoxynucleoside analogues (dR= deoxyribose) 
 
Nowdays, photo-switchable compounds are becoming increasingly popular for a 
series of biological applications based on the reversible photo-control of structure and 
function of biomolecules. The biological activities of those compounds are altered by 
light-triggering [35]. Among the many applications of photo-switchable compounds, 
biocatalysis [36, 37], ion transport [38, 39], cell adhesion [40], and protein folding [41, 
42] are vital. For instance chemical modification of nucleotides, peptides, proteins, and 
lipids with azobenzenes have been investigatied as photo-switchable chromophores [43, 
44]. Photoactivity of coumarin has also been the great interest for the researcher. For 
example, it was discovered by Ciamician and Silber in 1902 that coumarin significantly 
undergoes photodimerization under sunlight [45]. Coumarin dimer forms via the 
*2πs+2πs+ cycloaddition of a cyclobutane ring under different reaction conditions by 
photoirradiation. However, photoactivity of coumarin in DNA is still unknown. Thus, we 
developed a strategy for the incorporation of coumarin into ODN and studied the photo-
physical activity of coumarin-incorporated DNA. 
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Triazoles belong to a class of compounds called azoles. Five-membered aromatic 
ring azoles contain one nitrogen atom and any other heteroatoms of nitrogen, sulfur, or 
oxygen. Its continued use is increasing exponentially due to its reliability, non-toxicity, 
water solubility, regiospecificity, readily available starting materials as well as a 
tolerance to a wide variety of functional groups [46]. Triazoles have a versatile impact 
on industrial research and production such as hydraulic fluids, agrochemicals 
(fungicides), photochemical products [47, 48], and drug discovery research such as being 
used as reducing tumor cell proliferation drugs for cancer treatment [49].  
 
1.3 “Click” Chemistry 
“Click”chemistry was employed to conjugate selected compounds with 
nucleosides (Scheme 4). This method was first introduced by Barry Sharpless in 1999 at 
the 217th American Chemical Society annual meeting. Since then, it has been widely 
used for being both versatile and inexpensive [50, 51]. This reaction is more commonly 
known as a 1,3-dipolar cycloaddition [52, 53+; two π-electrons are supplied by the alkyne 
and four are supplied by the dipolar compound. Since this method formes a cyclic 
triazole (Scheme 4) from an alkyne and an azide, this type of reaction was classified as a 
Copper-(I) catalyzed Azide-Alkyne Cycloaddition (CuAAC) [54]. This is the most 
prominent example of “click” chemistry *55, 56] and takes place with a wide variety of 
conditions and works efficiently in many organic solvents as well as aqueous media to 
generate a stable, stereospecific, and easily purified product.  
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+N N N N
N N
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Scheme 4. Cu[I]-catalyzed azides-alkynes cycloadditions (CuAAC)  
This reaction is clean, fast, high-yielding, bioothrogonal, and highly tolerant of a 
variety of functional group. That is why “click” chemistry has been significant in its 
application to the nucleic acid field and is a powerful tool for DNA modification by 
promoting the ability for researchers to incorporate the procedure into biological 
systems.  
 The modified ODN products are very stable under these reaction conditions due 
to the formation of a fairly rigid triazole linker. “Click” reaction is very useful for the 
labeling of ODN with fluorophores [57-59] under mild conditions which has wide 
application in the emerging field of cell biology and functional proteomics. 
 In addition to fluorophore labeling of DNA, the “click” reaction has been widely 
applied for preparing various functionalized ODNs, such as dumbbell ODNs, small-
molecule DNA hybrids, and other modified ODNs [60-63]. This strategy uses the stable 
and easily prepared ODN precursors for preparing Dumbbell ODNs with an extra 
functional group, which enables us to functionalize DNA and RNA with appropriate 
properties for development of ODN therapeutics.Among the many other applications; 
DNA conjugation [64, 65], DNA nanomaterials, drug discovery], labeling [66, 67], ligation 
[68, 69], cross-linking [70, 71], and the formation of triplex are magnificent.  
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1.4 DNA Interstrand Cross-link (ICL) 
The separation of the two strands of a DNA double helix is essential for cellular 
processes such as replication and transcription. ICLs are formed by covalently linking two 
DNA complementary strands together, physically preventing the double helix from 
opening, which can block DNA replication and transcription therefore leading to DNA 
mutations and/or cell death. Certain agents including bifunctional alkylating agents, 
platinum compounds, and psoralen can produce covalent adducts with DNA bases on 
both strands of DNA, leading ultimately to the formation of ICLs. In general, small 
molecules and modified ODNs that cross-link DNA are potentially useful tools for 
mechanistic studies, in biotechnology applications [72-76], in therapeutic applications 
[77, 78]. In addition, chemical agents capable of inducing ICLs have been developed for 
many biological applications, such as for DNA damage and repair studies [79-83], for 
nucleic acid detection [84,85], for targeting telomeric G-quadruplex structures [86, 87], 
and most importantly for the construction of DNA nanomaterials [88] as DNA has the 
potential to be a remarkably useful technological material.  
Typically manipulating DNA nanostructures is challenging, via external force and 
repeated thermal changes, to control the positioning of various nano-components with 
nanometre-scale precision. Cross-linking of DNA strands is effective to stabilize DNA 
nanostructures, because of the extremely tight space on the nanostructures where DNA 
strands are entangled tightly and intricately. DNA cross-linking has been demonstrated 
as a scaffold for the assembly of organic and inorganic nanomaterials [89-94] which 
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could play a significant role on the next-generation nanofabrication and can be used as a 
possible wire for transporting electrical signals [95]. DNA reveals excellent abilities for 
site-selective immobilization and ordering of metal nanoparticles in one to three 
dimensions [96-100]. DNA also can form complexes with functional nanomaterials by 
linking DNA with single-wall carbon nanotubes (SWCNTs), which can then be used as 
nanoscale electrical contacts for probing electron transport in DNA. 
Several chemical methods have been dveloped for inducing ICL formation, such 
as photoirradiation, oxidation, reduction, fluoride induction, and H2O2 induction [101]. 
Even though these conventional methods are effective for achieving ICL they are often 
difficult to control and typically employ chain-like reactions species such as radicals or 
cations because these reactions often require the use of an initiator and the addition of 
thermal energy to initiate ICL. Therefore photoirradiation was used to form ICL which 
was developed by Plambeck in the 1950’s. Photoirradiation is a non-invasive method 
with high spatio-temporal resolution and offers the option of orthogonality. Most of the 
photoirradiated ICL materials could be cleaved to single strands with low wavelength UV 
light. Many modified nucleosides can induce DNA ICL formation upon photo irradiation, 
which has found wide applications in producing photoresists, printing plates, inks, 
coatings, adhesives, biological and biomedical applications. Photo-cross-linking is also 
applied in the fields of tissue engineering scaffolds and drug discovery.  
Photo-cross-linking with coumarin does not involve any additional molecule 
because coumarin is first introduced into the DNA strand, and therefore it may be a 
promising method to tightly stabilize DNA nanostructures with small deformations. 
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Coumarin introduced in the modified ODN binds to an adjacent pyrimidine base in the 
complementary strand via 350 nm UV irradiation. When the bonding partner is a 
thymine base, the efficiency of photo-cross-linking with coumarin is considerably higher, 
about 87% in the various sequence sets. Thus, the DNA photo-cross-linking using 
coumarin has great potential for tightly stabilizing DNA nanostructures with high yield 
without large structural deformations. 
The bases in a DNA duplex must have van der Waals interactions and the bonds 
involved must have molecular orbitals that overlap for the generation of ICL. Since all 
bases absorb specific UV light and ICL takes place under photolytic irradiation on 
functional subunits under native conditions, UV light induction was chosen for photo-
crosslinking. The spectral properties of DNAs arise from the bases by absorbing UV light 
maximally around 260 nm. The absorption of a photon by the base causes them to enter 
an excited state which transforms the electronic structure and chemical properties and 
cause ICL of DNA bases to other nucleotides. Another important aspect of UV is under 
the low-intensity of UV irradiation conditions.The most common types of photoproducts 
formed are cyclobutane dimers and pyrimidine 4-6 dimers. The formation of 
cyclobutane dimer involves two covalent bonds between the C5 and C6 atoms of 
pyrimidines and between the N7 and C8 atoms of purines. In this research, switching 
wavelength UV photoirradiation was applied for the coumarin induced photo-reversible 
ICL study in DNA. 
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Chapter 2 
Subject of the work  
2.1 Photo-Switchable DNA Interstrand Cross-Link (ICL) Formation by Coumarin-
Modified 2’-Deoxythymidine (dT) 
 
Photo-switchable compounds find many biological applications because of their 
photolytic reversibility of both structure and function. Coumarin derivatives show many 
advantages such as high fluorescence quantum yield, large Stokes shift, excellent 
photostability and low toxicity. They have been widely used in the fields of biology, 
medicine, and cosmetics. They have also been used as fluorescent chemosensors for 
DNA, RNA, and protein detection. However, there is no report about the photo reactivity 
of coumarin with DNA. Our attention was drawn to coumarin-DNA photo activity as this 
will provide new insights into the biochemical properties of coumarins and the possible 
toxicity. Based on the idea that if a compound absorbs at a higher energy then it will 
show emission and relaxation at a corresponding higher energy. We reasoned that 
because coumarin absorbs energy at a longer wavelength than ODN (λabs = 275 nm and 
260 nm respectively), it may exhibit emission at a longer wavelength than DNA. For this 
reason, coumarin-conjugated nucleosides were designed, incorporated into DNA and the 
photophysical properties were investigated upon UV irradiation. The primary focus of 
this chapter involves the study of coumarin’s photoreactivity with DNA. 
Coumarin-conjugated dT was synthesized and incorporated into ODN and its 
photophysical activity was studied. Coumarin-induced ICL was formed by UV irradiation 
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at 350 nm. The ICL site in coumarin-incorporated ODN was determined by hydroxyl 
radical cleavage of gel-purified ICL. LC-Mass study was employed followed by selected 
ion chromatogram of ICL materials to determine the structure of ICL. The coumarin-
induced ICL significantly cleaves back to its original single strands by UV light irradiation 
at a lower wavelength. The 32P-ATP labelled ICL and single stranded ODNs were 
identified on the basis of their electrophoretic mobility in 20% denaturing PAGE.  
 
 The coumarin modified dT (1) was synthesized by “click” reaction between the 
azide-modified dT (2) and alkyne-modified coumarin (3) [66]. For solid phase synthesis of 
ODN containing 1, the corresponding phosphoramidite 4a was prepared. The 4, 4′-
dimethoxytriphenylmethyl (DMT) residue was introduced for protecting 5’-OH functional 
group of compound 1. The DMT-derivative was converted into the phosphoramidite 4a 
with standard synthesis method.    
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In order to study the potential biological properties of coumarin and the effect of 
coumarin on DNA, a series of ODN (6a-15a) were synthesized by solid phase synthesis 
using the protocol of phosphoramidite chemistry. Complementary strands were also 
synthesized following the same procedure. The ODN duplexes were formed by 
hybridization between coumarin modified ODNs and the complementary strands. The 
ODN duplex was photo-irradiated at 350 nm for 50 minutes using a Rayonet 
Photochemical Chamber Reactor (Model RPR-100), thus forming an ICL. A wavelength of 
350 nm was chosen because near-UV light (>300 nm) is compatible with living cells and 
is almost completely non-absorbed by most biological molecules with the exception of 
coumarin-modified ODNs. The specific wavelength was chosen because coumarin 
moiety excites to singlet and triplet excitation states upon irradiation with 350-nm UV 
light to form cyclobutane. Several duplexes of ODN were designed using coumarin-
incorporated ODN with different opposing sequences and flanking sequences for broad 
analysis of both the ICL reaction site and possible mechanisms. Selectivity study and 
mass spectra analysis indicated that coumarin induced ICL formation via a (2π+2π) 
photodimerization reaction when irradiated in the Ultraviolet-A (UVA) region. To analyze 
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the photo-reversibility of ICL materials, the ICL materials were photoirradiated at a 
wavelength of 254 nm; the cyclobutane ring in ICL was cleaved and reverted to its initial 
single stranded ODN structures which were confirmed by MALDI-Mass analysis. 
So far, neither unsubstituted nor substituted pyrimidines have ever been applied 
as components of coumarin photoswitches ICL. This feature would be one of the 
important milestones for the photo activity of DNA. Ten distinct complete cycles of 
photoreversible reaction were investigated to verify the ratification of this exceptional 
photoswitchability.   
2.2 Synthesis of Coumarin-Modified 2’-Deoxycytosine (dC) and 2’-Deoxyadenosine 
      (dA) by “Click” Chemistry 
 
Modified purine and pyrimidine nucleotides show distinct properties as active 
biological agents. Coumarins and their derivatives are of great interest in the field of 
medicinal chemisttry due to widespread pharmacological properties of coumarin and 
the possibility to screen them as several novel therapeutic agents. Moreover, coumarin 
fluorescence can and has been proven as a tremendously effective probe of the physical, 
structural and chemical properties of a wide range of heterogeneous host systems 
including: molecular hosts, micelles, polymers, and porous, glassy, and crystalline solids. 
Potential ICL property of coumarin-modified pyrimidine which has recently been 
reported [102] and has been explained in the previous chapter of this thesis. In addition, 
coumarin-conjugated dT derivative 4 showed some anticancer activity from screening in 
60 human cancer cell lines. Therefore, there is a certain need to expand the modification 
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of dA and dC with coumarin, which might result in important biomolecules with 
interesting biological properties and lead essential applications. 
 
In order for conjugation of coumarin into dA and dC, Cu-mediated azide-alkyne 
“click” ligation was undertaken between alkyne modified coumarin 3  and azide modified 
dA and dC, leading to 6-(4-methylchromen-2-one-1,2,3-triazol-1-yl)-9-[2-deoxy-β-D-
ribofuranosyl]adenosine (10) and 5-(4-methylchromen-2-one-1,2,3-triazol-1-yl)methyl-
2’-deoxycytosine (11).  
2.3   Modified 2’-Deoxythymidine (dT) and Oligodeoxynucleotide (ODN) Containing 
         Triazole and Phenyl-triazole: Synthesis and Properties 
 
Heterocyclic compounds have great importance in a wide variety of fields ranging 
from industrial to pharmaceutical chemistry. The ever-increasing demand for novel 
biologically active compound as well as widespread applications of 1,2,3-triazoles result 
in a continuous search for generating anolouges of 1,2,3-triazoles. Considering the broad 
spectrum of activities that triazoles exhibit; 1,2,3-triazole and it’s substituted triazole 
conjugated dT were synthesized as well as their physico-chemical and biological 
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characteristics were examined. Conjugation of 1,2,3-triazole (pKa = 9.3) and phenyl 
substituted 1,2,3-triazole into dT (pKa = 9.8) moiety were performed through a few 
synthetic steps. 5-(1,2,3-Triazol-1-yl)methyl-2’-deoxyuridine (5) and 5-(4-phenyl-1,2,3-
triazol-1-yl)methyl-2’-deoxyuridine (6) were easily obtained  by using the copper-
catalyzed alkyne-azide “click” cycloaddition reaction.  
For solid phase synthesis of ODN containing 5 and 6, the corresponding 
phosphoramidite 5d and 6d were prepared. The DMT residue was introduced in the 5’-
OH function leading to the DMT derivatives (5c and 6c), which were converted to the 
phosphoramidites (5d and 6d). In order for further analysis of the effect of triazole and 
phenyl-triazole on DNA, ODN-107 and ODN-15 were synthesized by solid phase synthesis 
using standard phosphoramidite chemistry protocol. Complementary strands were also 
synthesized following the same procedure. 
 
The modiﬁed ODN duplexes were found signiﬁcantly stabilized with the 
replacement of triazole and phenyl-triazole at 5-position of dT. Stability of ODN duplex 
was enhanced by modified nucleosides in a basic medium with higher pH value. The 
strongest stacking and most pronounced positive inﬂuence on thermal stability was 
found for the dT analogue at pH 8.  
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ICL formation was analyzed with triazole and phenyl-triazole modified ODN 
duplexes 20 and 21 upon UV photo-irradiation at 350 nm for 2 hours. The details 
analysis of ICL reaction under different pH showed that the highest cross-linking yield 
was observed in acidic condition at lower pH values.  
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Chapter 3 
Photo-Switchable DNA Interstrand Cross-Link (ICL) Formation by 
Coumarin-Modified 2’-Deoxythymidine (dT) 
 
3.1. Background 
Coumarin and coumarin-related compounds come from a wide variety of natural 
sources. These have been used as medicines since ancient era in Egypt and many other 
fields [103-110]. They have shown a significant therapeutic potential for many years in 
chemical biology research including anti-tumour effects, disease prevention, growth 
modulation, and anti-oxidant properties. Coumarins are also highly researched today 
due to their physiological, pharmacological [111], anti-tumour activity [112] and 
exhibited cytotoxic activity [113] but they also deserve further study to produce 
successful outcomes.  
In addition, the strongly fluorescent coumarin shows fluorescence and 
phosphorescence in the visible light range. Conjugation of fluorescent molecules to 
neocleosides is the great interest for nucleic acid chemistry. Netzel and coworkers 
utilized pyrene conjugates (Scheme 5) to study the redox processes in DNA oligomers 
and duplexes at specific base sites [114]. Seela and coworkers also reported enhanced 
fluorescent properties with an ethynyl linker at the 7-position of deaza-adenosine [115]. 
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Scheme 5.  Pyrene-extended dT and ethynyl-extended dA. 
 
Modification of nucleosides in DNA are significantly important in nucleic acid 
chemistry research, for instance, modified nucleosides construct DNA-based reversible 
photoswitches and photo-manipulation of DNA. Photo-inducible quinone methide 
formation from biphenyl or binol quaternary ammonium salts was reported recently by 
Freccero, Zhou and their coworkers [116-118]. Quinone methides are highly reactive 
electrophiles which efficiently form ICL in DNA double stranded duplex. They also 
reported the formation of vinylidene−quinone methides from 2-alkynylphenols [119]. 
Psoralens are also an excellent group of naturally-occurring photoreactive products also 
known as “fuoro-coumarin,” which have been used as probes of nucleic acid structure 
and function. They have also been used for therapeutic gene modulation and the study 
of DNA damage and repair [120-122]. UVA-activated (320-400 nm) psoralen can 
effectively generate up to 40% ICL in duplex and triplex DNA [123] (Figure 4). The 
cytotoxic psoralen-induced ICLs induce unwinding of the DNA duplex and significantly 
block the replication and transcription to damage the cell. 
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Figure 4. Photoadduct formation of psoralen under UVA-irradiation 
 
Coumarin is structurally related to psoralen; only one furan ring addition to 
coumarin can form psoralen. Coumarin has excellent photostability and low toxicity, has 
been widely used in the fields of biology, medicine, cosmetics, and as fluorescent 
chemosensors for DNA, RNA, and protein detection [124, 125]. Photoactivity of 
coumarin is also significant, such as photodimerization of coumarin was discovered by 
Ciamician and Silber in 1902, in which sunlight was used to irradiate and synthesize 
dimerized coumarin product.  Schenck and coworkers used 1H NMR spectroscopy to 
determine the structure of possible dimers that were produced from the irradiation of 
coumarin at different reaction conditions. In the 1970s, they concluded that the dimer 
was formed via the *2πs+2πs+ cycloaddition formation of a cyclobutane ring. As far 
concerned, there is no report about the photo-physical activity of coumarin with DNA. 
Therefore, in order to determine the photo-physical properties of coumarins in DNA, 
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coumarin conjugated dT was designed and investigated for the first time photo-
switchable ICL formation in DNA upon UVA irradiation.  
In this project, coumarin was conjugated to dT by Cu-catalyzed azide-alkyne 
cycloaddition “click” reaction using azide-modified dT (2) and an alkyne-modified 
coumarin (3). Compound 1 was converted to its phosphoramidite building block 4a 
(Scheme 6) under standard conditions after DMT residue was introduced in 5’OH 
function. ODNs containing 1 were synthesized via automated solid-phase synthesis using 
4a and their structure was confirmed by MALDI-TOF-MS analysis. 
 
Scheme 6. The structure of coumarin-modified dT 
 
In order to study the biological properties of coumarin and the effect of 
coumarin in DNA, a series of ODNs were synthesized using protocol of phosphoramidite 
chemistry by solid phase DNA synthesizer. Complementary strands were also 
synthesized following the same procedure. ODN duplex was formed by hybridization 
between coumarin modified ODN and complementary strands. ICL was formed by the 
photo-irradiation of ODN duplex at 350 nm for 50 min (Figure 5). Photo-irradiation was 
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employed which has several advantages over thermal or redox induced ICL formation 
procedure such as speed, low cost of materials and energy, and the ability to selectively 
cure systems as well as solvent-free formulations [126-133]. In addition, unlike many 
photo-initiated reactions these photo-crosslinking reactions via *2π+ 2π+ cycloaddition 
do not suffer by oxygen inhibition. Broad analysis of ICL reaction was performed with 
different opposite sequences and flanking sequences effect for the determination of 
selectivity of ICL site. The ICL site in modified ODN was confirmed by hydroxyl radical 
cleavage experiment of gel-purified ICL. The structure of ICL was determined by LC-
MS/MS analysis of selected-ion chromatogram (SIC). Further analysis showed that ICL 
materials were again photo-reversed to its initial single strands by UV-irradiation at 254 
nm (Figure 5).  
 
 
Figure 5. The structure of ODN single strands and ICL 
 
The photochromic behavior of these compounds was observed via gel electrophoresis 
analysis followed by UV photo-irradiation at variable wavelengths. Ten distinct 
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absorption bands were investigated to verify the ratification of this exceptional 
photoswitchability. This feature is certainly the important milestone for the 
photoswitchable DNA study in nucleic acid research.  
  
3.2 Results and Discussions 
3.2.1 Synthesis of Coumarin-Modified dT (1) 
For our preliminary investigation we choose to synthesize coumarin-modified dT 
(1) (Scheme 7). First, 7-ethynyl-4-methyl-chromen-2-one (3) and 5-azydomethyl-2’-
deoxyuridine (2) were synthesized by following the known procedure [134+. “Click” 
reaction was performed between alkyne-modified coumarin 3 and azide-modified dT 2  
under the catalysis of sodium ascorbate and copper sulphate in water solution to 
produce 5-(4-methylchromen-2-one-1,2,3-triazol-1-yl)methyl-2’-deoxyuridine (1) in 74% 
yield. 
 
Scheme 7. Synthesis of coumarin-conjugated dT 
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3.2.2     Synthesis of the Phosphoramidite Derived from 1 
 
For studying the photophysical characteristics of coumarin in DNA, solid phase 
synthesis was used to synthesize ODNs containing compound 1, the corresponding 
phosphoramidite (4a) was synthesized from coumarin conjugated nucleoside 1 (Scheme 
8). At first, DMT residue was introduced in 5’OH functional group of 1 with 68% yield. 
The DMT derivative 4 was converted into the phonphoramidite (4a) in 80% yield by 
phosphorylation under Ar atmosphere using diisopropylethylamine and 2-cyanoethyl-
N,N-diisopropylchlorophosphoramidite. 
 
Scheme 8. Synthesis of phosphoramidite derived from 1 
 
3.2.3     Coumarin-Modified Derivatives of dT and Anticancer Activity Test 
Modified nucleosides attract great attention because of their biological activities 
such as antiviral [135-137] and anticancer activities [138, 139].  Coumarin was chosen for 
the modification because it acts as an anti-inflammatory, antibacterial, antifungal, 
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antiviral, anticancer, antitubercular, anticonvulsant, antiadipogenic, antihyperglycemic, 
antioxidant, and contains neuroprotective properties. Bacteriostatic and anti-tumor 
activity of coumarin make it attractive for further backbone derivatisation and this 
further validates that coumarin has great potential for use in/as a therapeutic agent. For 
instance, Weber [140] and co-workers have shown that coumarin and its metabolite 7-
hydroxycoumarin have antitumor activity against several human tumor cell lines. Much 
research also showed that both coumarin and their derivatives have been investigated as 
potential inhibitors of cellular proliferation in various carcinoma cell lines [141, 142]. 
Moreover, 4-hydroxycoumarin and 7-hydroxycoumarin inhibited cell proliferation in 
gastric carcinoma cell lines [143]. Therefore, coumarin-modified dT nucleosides have 
been synthesized for the purpose of investigating anticancer activity against the 60 
human cancer cell. Compound 4 was identified as potential anticancer active analog 
among the coumarin-modified analogs 1, 4, and 4a (Scheme 9). 
 
                            Scheme 9. Coumarin-modified dT 
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3.2.4 Bio-physical Properties Study of 1 in ODNs  
3.2.4.1 Synthesis of Modified ODNs (7a-15a) Containing 1 
Synthesis of fluorescent ODNs is one of the great important attractions in nucleic 
acid research. Different research groups have already been using fluorescent probes to 
investigate the nucleic acid structure, dynamics, and recognition. To accomplish 
coumarin incorporated ODN 7a-15a (Table-1), Automated DNA synthesizer was used to 
incorporate phosphamadite building block 4a via protocol of standard solid phase 
phosphoramidite chemistry. The average coupling yield was above 75%. After cleavage 
from the solid support, ODNs were deprotected with an ultra-mild deprotection 
condition (25% aq. NH3, 1 h, room temperature). Complementary strands were also 
synthesized following the same procedure. Purification of crude ODNs were 
accomplished by 20% polyacrylamide gel electrophoresis and sequence of ODNs were 
confirmed by MALDI mass. 
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Table 1. List of coumarin-modified ODNs (1 = dT (Cm) 
 
 
ID ODN Sequences 
7a 5'-dAGATGGAT1TAGGTAC 
12a 5'-dAGATTTTT1TTTGTAC 
13a 5'-dAGATTAAA1AAAGTAC 
14a 5'-dAGATTCCC1CCCGTAC 
15a 5'-dAGATTGGG1GGGGTAC 
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Table 2. List of Complementary Strand ODNs. 
 
ID ODN Sequences 
6a 5'-dAGATGGATTTAGGTAC 
6b 3'-dTCTACCTAAATCCATG 
9b 3'-dTCTACCTACATCCATG 
10b 3'-dTCTACCTATATCCATG 
11b 3'-dTCTACCTAGATCCATG 
12b 3'-dTCTAAAAAAAAACATG 
13b 3'-dTCTAATTTTTTTCATG 
14b 3'-dTCTAAGGGGGGGCATG 
15b 3'-dTCTAACCCCCCCCATG 
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Fluorescence study of coumarin-incorporated ODN: To verify the integrity and 
composition of the coumarin-containing ODNs, fluorescence spectroscopy was used as 
an alternative method for investigating the structure and properties of ODN. 
Characterization and information of ODN can be obtained with the use of spectroscopic 
methods in which a fluorescent probe is incorporated into ODN at a specific site. The 
presence of fluorescence signal from modified ODN molecules offers the advantage over 
the non-fluorescent signals from natural or non-modified ODN. Therefore for the 
determination of coumarin-modified dT (1) was incorporated into single strand ODN and 
was studied and was observed to be strongly fluorescent as emission spectrum displays 
a maximum at 410 nm compared to non-modified ODN (Figure 6). The fluorescent 
activity of modified ODN proved the presence of coumarin in synthesized ODN and 
coumarin modified dT (1) was incorporated successfully. This experiment also confirmed 
that the coumarin modified nucleoside is stable toward multiple cycles of ODN synthesis. 
In addition to fluorescence measurement, MALDI mass spectroscopy was used to 
characterize the modified ODNs. Mass spectrum identified the same mass as the 
calculated oone (Table 3), which also proved that ODN was modified successfully with 
coumarin by incorporating coumarin conjugated dT (1) into synthesized ODN via solid 
phase DNA synthesizer. The reaction mixture for the experiment contained 5.0 μM DNA, 
100 mM NaCl, and 10 mM phosphate buffer (pH 7.0).  
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Figure 6. UV emission spectra of coumarin modified ODN (5 µM, λex = 350 nm, slit width 
= 15 nm; λem = 410 nm, slit width = 2.5 nm). 
 
Table 3. MALDI-MS analysis of synthesized ODNs. 
 
ODN ID ODN Sequences 
MALDI-MS Analysis 
Calculated Found  
7a 5'-dAGATGGAT1TAGGTAC 5187.4 5187.0 
12a 5'-dAGATTTTT1TTTGTAC 5091.3 5091.0 
13a 5'-dAGATTAAA1AAAGTAC 5147.4 5147.5 
14a 5'-dAGATTCCC1CCCGTAC 5003.3 5003.3 
15a 5'-dAGATTGGG1GGGGTAC 5243.4 5243.3 
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Hybridization of ODN single strands – Modified single stranded ODNs were 
hybridized with complementary strands following the standard procedure (Table 4).  
After quantification, radiolabeling of modified ODNs was carried out according to the 
standard protocols with [γ-32P] ATP. The [γ-32P] ATP-labelled ODNs were mixed with 1.5 
equiv of their complements °at room temperature in a buffer of 100 µM potassium 
phosphate, pH 7.0, and 1M NaCl, then heated to 65°C followed by slow-cooling to room 
temperature overnight. 
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Table 4. List of coumarin-modified ODN duplexes 
ODN duplexes Sequences 
66 
6 
 
77 
7 
 
9 
9 
 
10 
10 
 
11 
11 
 
12 
12 
 
13 
13 
 
14 
14 
 
15 
15 
 
 
 
36 
 
 
3.2.4.2 Coumarin-Induced ICL Formation and Analysis 
Photoirradiation usually forms ICL that result from a cyclic covalent bond 
between unsaturated bonds of two different compounds such as coumarin, cinnamate, 
and maleimides [144-148+. They undergo a *2π+2π+ cycloaddition when exposed to long 
wavelength UV photoirradiation. Coumarin derivatives undergo a photodimerization 
reaction under the ultraviolet-A (UVA) region irradiation [149-151]. UVA wavelength of 
350 nm was used which is compatible with living cells and the coumarin moiety can be 
excited in this irradiation to form singlet and triplet excitation states to generate ICL 
materials.   
For the ICL formation study, coumarin-functionalized ODNs were labelled with *γ-
32P] ATP at the 5' position of modified ODN and hybridized with complementary strand. 
The hybridized ODN duplexes were photo-irradiated at 350 nm for 50 min using a 
Rayonet Photochemical Chamber Reactor (Model RPR-100). As we expected, a new band 
of ICL product was observed with the duplex 7 in the PAGE analysis after UV-irradiation. 
The migration of new band of ICL was severely retarded for duplex 7 relative to non-
modified and unreacted ODN duplex 6 after UV photo-irradiation which is indicative of 
ICL formation (Figure 7). Single-stranded ODN was identified on the basis of their faster 
electrophoretic mobility. 
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Figure 7. PAGE analysis of ICL formation for ODN duplex-6 and duplex-7 
 
3.2.4.3 Sequence Effect on Coumarin-induced ICL  
In order to determine the selectivity of coumarin-induced ICL, the reactivity 
patterns of coumarin were further investigated with the coumarin-modified ODN 
duplexes 6-11, which contain coumarin-modified ODNs hybridized with opposing 
sequence complementary of coumarin with dA, dC, dT, and dG in complementary 
strands. Lanes 6-9 are for duplexes 6-11 respectively, where in lanes 7-9, coumarin 
modified dT (1) is opposite to four different nucleosides. Decreased ICL yield was 
observed in the order of dT (10, 69%) > dC (9, 55%)> dA (7, 43%) > dG (11, 24%) (Figure 
8). This result indicates that 1 has a higher reactivity towards pyrimidines than purines.  
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Figure 8. PAGE analysis of ICL formation from duplexes 6-11 
 
In order to fully investigate the reactivity of 1 towards the four canonical 
nucleosides, several variations in the complementary sequence around the central 
coumarin were used for this furthur study. DNA duplexes 12-15 with only dA, dT, dG, or 
dC surrounding the ICL site were used and the ICL efficiency was examined (Figure 9). All 
the substrates used were annealed to the complementary ODNs to generate duplexes. 
Among these duplexes, the highest ICL yield wasobserved with duplex 13 (dT, 87%), 
while no ICL was found with duplex 14 (dG) (Figure 9). Although duplexes 12 (dA) and 15 
(dC) resulted in about 4% and 7% ICL respectively, the reaction of dC or dA with 1 is 
much slower than that of dT with 1. All these results supported that coumarin has much 
higher selectivity with dT than with dC and dA. 
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Figure 9. PAGE analysis of ICL formation with duplexes 12-15 
 
3.2.4.4 Properties Study of Coumarin-induced ICL  
Fluorescence intensity was sharply dropped for the cross-linked coumarin-DNA 
adduct (Figure 10). As the unsaturated bonds of coumarin and dT were converted to the 
cyclobutane to form the ICL between two ODN single strands, the extented conjugation 
of the coumarin moiety was decreased, and the wavelength of absorbance was reduced 
from 350 nm to 254 nm. The reaction mixture contained 5.0 μM DNA, 100 mM NaCl, 
and 10 mM phosphate buffer (pH 7.0). This suggests that the ICL formation may lead to 
the destruction of the conjugation system of coumarin moiety. This property allows 
rapid, direct, and efficient monitoring of the DNA cross-linking process on time via a 
non-invasive method instead of employing a traditionally-used harmful 32P-labelling 
method in biochemical research. The novel method could be introduced as an effective 
way in biology for DNA cross-linking study and allow real-time detection without 
disrupting native cell environment. 
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Figure 10. Fluorescence emission spectra of 10 µM ODN 6a, ODN 7a and  ICL products in 
100 mM NaCl and 10 mM pH 7 phosphate buffer solution (λex = 350 nm, slit width = 10 
nm; λem = 392 nm, slit width = 10 nm). 
Stability study of ICL product - Investigation was performed to confirm the 
stability of ICL materials after separation from cross-linking reaction mixture. The ICL 
was purified by 20% denaturing PAGE after UV irradiation at 350 nm for 50 min. The 
isolated and dried ICL products obtained from duplexes 7-12 were dissolved in 1.0 M 
piperidine (20 μL) and incubated at 90 oC for 30 min. The samples were subjected to 
electrophoresis on a 20% denaturing polyacrylamide gel (Figure 11). Lane 1, the isolated 
ICL was used as control; Lane 2, single stranded (SS) ODN 7a was used as control; Lanes 
3-8 for piperidine treatment of ICL products at 90 oC for 30 min (lane 3: ICL product 
formed from duplex 7; lane 4: ICL product formed from duplex 8; lane 5: ICL product 
formed from duplex 9;lane 6: ICL product formed from duplex 10;lane 7: ICL product 
formed from duplex 11; Lane 8, the ICL products formed from duplex 12. 
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Figure 11. PAGE analysis ofICL materials after piperidine treatment  
3.2.5     Determination of the ICL Site 
After series analysis of ICL formation for the coumarin-modified ODN duplexs upon UV 
photoirradiation, it was concluded that coumarin-derived dT is conjugated mainly with a 
dT (8a) (Figure 12) and as minor ICL with dC (8b) where the dC moiety was deaminated 
and converted to a 2’-deoxyuridine (dU), and to a lower extent and insignificant ICL 
formed with dA (8a). 
 
 
 
Figure 12. The cross-linking site induced by coumarin moiety in duplex 7.  
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3.2.5.1 Hydroxy Radical Cleavage Reaction for ICL Site Determination 
Hydroxy radical cleavage experiment was performed to investigate the cross-
linking site in coumarin-modified ODN. The ICL product was isolated for this experiment 
from UV-treated ODN duplex 7. G+A sequence reaction and Fe(II)·EDTA cleavage 
reactions of the separated 32P-labelled cross-linked product (0.1μM) were performed in 
a buffer and H2O2 for 3 min at room temperature and then quenched with 100 mM 
thiourea (10 μL). Samples were lyophilized and incubated with 1M piperidine (20 μL) at 
90 oC for 30 min, dissolved in 20 μL H2O, 90% formamide loading buffer (1:1) and 
subjected to 20% denaturing PAGE analysis. In figure 13A: 7a was radiolabeled at 3’-
terminus: lane 1, G+A sequencing; lane 2, Fe·EDTA reaction of 7a; lane 3, piperidine 
treatment of ICL isolated from UV irradiation of 7a and 6b at 90 °C for 30 min; and in 
figure 13B: 7a was radiolabeled at 5’-terminus. Lane 1, G+A sequencing; lane 2, Fe·EDTA 
reaction of 7a; lane 3, Piperidine treatment of ICL isolated from UV irradiation of 7a and 
6b at 90 °C for 30 min. Both figure 13A and B indicated that ICL was formed at the 9th 
position which is coumarin-modified dT (1) of ODN 7a. 
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Figure 13. Hydroxy radical cleavage analysis for duplex 7 
Histogram diagram of Fe (ii) EDTA cleavage: To substantiate the results of hydroxy 
radical cleavage reaction, histogram diagram experiment was performed for the 
determination of the ICL site at the coumarin-modified ODN via hydroxy radical cleavage 
of the ICL product isolated from UV-treated ODN duplex 7. This experiment determines 
the covalent bonding of ICL site of modified ODN with the complementary strand. ICL 
cleavage of Fe·EDTA product was observed in figure 14A and 14B at the 9th position 
which is coumarin-modified dT (1) of ODN 7a in duplex 7. 
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Figure 14. Histogram diagram of duplex 7. 
 
3.2.5.2 LC-MS Analysis for Determining ICL Site via Enzymatic Digestion 
 
ICL occurred mainly with 1 in coumarin-modified ODN 7a that was determined by 
footprinting of hydroxyl radical reaction and histogram diagram experiment of gel-
purified ICL. However, the exact ICL site in the complementary strand might be multiple. 
To exploit this further, LC-MS and MS/MS was used to determine the identities of the 
nucleobase(s) in the opposite strand that is(are) cross-linked with the coumarin-
modified dT moiety. Isolated ICL from duplexes 7 and 9 with a cocktail of four enzymes 
to release the ICL as a dinucleoside remnant and subjected the resulting mixture to LC-
MS and MS/MS analyses. The instrument was set up for monitoring the fragmentation 
of thedinucleoside remnant of putative ICL products as [M+H]+ ions in the positive-ion 
mode. As we expected, LC-MS/MS results revealed in the digestion mixture as 
dinucleosides, in which the coumarin-derived dT is conjugated to complementary strand 
with a dT and to dC, detected as the deaminated product dU (dC moiety was converted 
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to a dU). Expected LC-MS spectra of dimers dT-1 (A) and dC (dU) - 1 (B) were found from 
the digestion mixture of ICL products (Figure 15) 
 
 
 
 
 
 
 
Figure 15. LC-MS spectra of dinucleosides obtained from enzymatically digested ICL 
 
3.2.6     Selected-ion Chromatogram (SIC) Analysis for ICL Structure Determination 
Previous analysis have shown that ICL took place between nucleoside 1 in 
coumarin-modified ODN and dT and dC in the complementary strand and all ICL 
products were stable to heating in phosphate buffer or 1.0 M piperidine. It was also 
determined that dT had a much higher reactivity than dC towards the coumarin moiety. 
Several research group investigated that psoralen reacts with pyrimidine bases of dT and 
dC via [2+2] cycloaddition reaction involving either the 3, 4-double bond of the pyrone 
ring or the 4',5'-double bond of the furan ring which yields a "furan-side mono adduct" 
dT(Cm)-dT dT(Cm)-dC(dU)  
(A) MW Calculated: 710 g/mole, Found: 710,     (B) MW Calculated: 696 g/mole, Found: 696 
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[152].  Psoralens react primarily with dT in DNA and uridine in RNA although a minor 
reaction with cytosine also occurs [153]. Similarly, LC-Mass analysis of selected ions after 
neutral loss of a 2-deoxyribose by enzymatic digestion of coumarin induced ICL product 
confirmed that upon exposure to 350 nm of UV light, coumarin undergoes [2+2] 
cycloaddition reaction similarly with its neighboring dT and dC to give ICL products. 
LC-Mass analysis of major fragmentation; (dT-1) - The MS/MS analysis for monitoring 
the [M+H]+ ion of dT-1 revealed two major peaks m/z 710 (17)  594 (21) transition, 
which monitors the neutral loss of a 2-deoxyribose (Figure 16). Product ions of m/z 470 
(22) and 478 (23) were also found in the MS/MS due to neutral losses of 2-deoxyribose 
by enzymatic digestion of ICL product. 
 
Figure 16. Fragmented ions of dT-1 from enzymatically digested ICL 
LC-Mass Analysis of major fragmentation; dU-1 - The MS/MS analysis for the 
selected-ion chromatogram (SIC) of monitoring the [M+H]+ ion of dU-1 revealed two 
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major pekaks m/z 696 (16)  580 (18) transition, which monitors the neutral loss of a 2-
deoxyribose (Figure 17). Product ions of m/z 456 (19) and 464 (20) were also found in 
the MS/MS due to neutral losses of 2-deoxyriboseby enzymatic digestion of ICL product. 
 
Figure 17. Major ion fragmentations for dU-1 from enzymatically digested ICL 
 
3.2.7 Kinetic Study of ICL 
To further substantiate the reactivity of coumarin in ODN towards dT and dC and 
dA, kinetics of ICL formation was analyzed. ICL formation was studied over different 
course of time. The final volume of 32P-labeled ODN duplex aliquots was 20 uL. 1M NaCl, 
10 mM potassium phosphate, pH=7 were mixed and UV irradiated at the prescribed 
times and immediately quenched by 90% formamide loading buffer, and stored at -20 oC 
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until subjected to 20% denaturing PAGE analysis. dT was found more reactive (kdT = 3.5 
± 0.5 × 10-3 (Figure 18) than dC (kdC =1.2 ± 0.2 × 10
-3) and dA (kdA = 0.8 ± 0.2 × 10
-3) 
towards coumarin moiety, which supports our previous experimental results. 
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Figure 18.  Kinetics ofcoumarin-induced ICL growth 
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3.2.8     Photoclevage Reaction of ICL Materials 
Photoreactivity of ICL materials - Several researches showed that photocleavage 
allows photocross-linking materials revert to their original structure [154-158]. 
Cyclobutane rings that are derived from α-truxxilate, β- or δ- truxinates, and the 
cyclobutane ring formed between coumarin and dT dimers reverse upon irradiation near 
250 nm. Coumarin groups were utilized to form cyclobutane in the mid 1960s at the first 
time by photoirradiation and at the late 1980s they were utilized for their reversibility 
[159-161]. Here, coumarin-induced ICL of ODN was further evaluated to determine the 
effect of UV light irradiation at lower wavelength. Interestingly ICL of ODN duplexes 
reverted to the original single stranded ODNs as anticipated, where cyclobutane ring 
structure between ODN strands opens to unsaturated bonds. Cleavage of the ICL 
products to two single stranded ODNs was ultrafast and 90% cleavage was completed 
within 60 S. 2.14 µM ICL solutions were used for this highly reversibile study of 
coumarin-induced ICL. The reactions were quenched by an equal volume of 90% 
formamide stop/loading buffer, and phosphorimage autoradiogram of 20% denaturing 
PAGE was used to analyze the photoreversible reaction (Figure 19). lane 1, ICL as control; 
lane 2, SS as control, lane 3,ICL formation reaction by irradiation of duplex 7 at 350 nm 
with 50 min; lane 4, reverse reaction by irradiation at 254 nm for 6 min for cleavage of 
ICL to single-stranded ODN. 
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Figure 19. PAGE analysis photoreversible ICL reaction 
 
MALDI-mass analysis of ICL cleavage to single strands - Cleavage of the ICL 
products into two single stranded ODNs was ultrafast and almost completed within 60 
sec by 254 nm irradiation. This process was also confirmed by MALDI-TOF-MS analysis, 
where both coumarin-modified ODN and the complementary strand were confirmed. 
For this analysis isolated ICL from duplex 7 was further irradiated at 254 nm for 6 min.  
The detected masses of two ODNs are 5185 Da and 4800 Da, which are identical to the 
coumarin-modified ODN 7a (Cal.: 5186.4 Da) and the complementary strand 6b (Cal.: 
4800.2 Da) (Figure 20). 
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Figure 20. MALDI-TOF MS spectra of single stranded ODNscleaved from ICL 
 
3.2.9 Multiple Cycle Photoreversibility Test of Coumarin Induced ICL  
The photoswitchablity of the ICL induced by coumarin-modified dT (1) was 
investigated in previous experiments. To analyze the constancy of photoswitchablity, 
the reversibility of ICL was examined by multiple cycles with duplexes 10, 12, 13, and 15. 
Fivecycle photoreversibility study of coumarin-induced ICL of duplex 10 – To analyze the 
multiple cycle photoswitchablity, duplex 10 was photoirradiated at 350 nm to generate 
ICL, and the ICL solution was again irradiated by lower wavelength UV light 254 nm for 6 
min to make a cycle. Four more consecutive cycles were completed by irradiation 
repeatedly. The reaction mixtures were collected each time and was quenched by an 
equal volume of 90% formamide stop/loading buffer and then electrophoresed on a 
20% denaturing polyacrylamide gel at 1200 V for approximately 2.5 h. Single-stranded 
ODN and ICL were identified on the basis of their electrophoretic mobility. The ICL 
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product of duplex 10 was analyzed as successfully reverted to single stranded ODNs 
upon 254 nm irradiation. Therefore duplex 10 is reversible upon switching wavelength 
of UV photoirradiation. 
ICL formation and cleaving to single stranded ODN are shown in figure 21 for 5 
cycles. Where in Lane 1, single stranded ODN 7a was run as constant; Lane 2, UV 
irradiation of duplex 10 at 350 nm for 50 min to form ICL; Lane 3, UV irradiation at 254 
nm for 6 min to cleave the ICL product leading to single stranded ODN; Lane 4, UV 
irradiation at 350 nm for 50 min to form ICL; Lane 5, UV irradiation at 254 nm for 6 min 
to form reversed single strand ODN. Lane 6; UV irradiation at 350 nm for 50 min to form 
ICL; Lane 7, UV irradiation at 254 nm for 6 min to form reversed single strand ODN; Lane 
8, UV irradiation at 350 nm for 50 min to form ICL; Lane 9, UV irradiation at 254 nm for 6 
min to form reversed single strand ODN; Lane 10, UV irradiation at 350 nm for 50 min to 
form ICL; Lane 11, UV irradiation at 254 nm for 6 min to form reversed single strand 
ODN; Lane 12, UV irradiation at 350 nm for 50 min to form ICL. 
 
 
     1(c)       2        3        4        5        6        7        8        9      10      11       12
ICL
Single Strands
     0         74      13       73      15        70     17        69      20      67       24       65
% of ICL
 
Figure 21. PAGE analysis of multiple cycles ICL photoreversibility study with duplex-10 
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In order to see the generalitiy of the phtoreversibility of ICLs formed from coumarin and 
dT, we investigated the photoproperties of the ICL formed with other independent DNA 
duplexex 13, 15, and 12. This process was repeated for 5 cycles. 
Fivecycle photoreversibility study of coumarin-induced ICL of duplex-13: - To 
analyze the multiple cycle photoswitchablity, duplex 13 was photoirradiated at 350 nm 
to generate ICL, and the ICL solution was again irradiated by lower wavelength UV light 
(254 nm) for 6 min to make a cycle. Four more consecutive cycles were completed by 
irradiation repeatedly. Similar to duplex 10, the ICL products generated from duplex 13 
by 350 nm irradiation were also reverted to single stranded ODNs upon 254 nm 
irradiation. Therefore ICL formation from duplex 13 is also reversible upon switching 
wavelength of UV photoirradiation. 
The reaction mixtures were collected each time and was quenched by an equal 
volume of 90% formamide stop/loading buffer and then electrophoresed on a 20% 
denaturing polyacrylamide gel at 1200 V for approximately 2.5 h. Single-stranded ODN 
and ICL were identified on the basis of their electrophoretic mobility.  
In figure 22; Lane 1, single strand ODN 13a; Lane 2, UV irradiation of duplex 13 at 350 
nm for 50 min to form ICL; Lane 3, UV irradiation at 254 nm for 6 min to cleave the ICL 
product leading to single strand ODN; Lane 4, UV irradiation at 350 nm for 50 min to 
form ICL; Lane 5, UV irradiation at 254 nm for 6 min to form reversed single strand ODN. 
Lane 6; UV irradiation at 350 nm for 50 min to form ICL; Lane 7, UV irradiation at 254 nm 
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for 6 min to form reversed single strand ODN; Lane 8, UV irradiation at 350 nm for 50 
min to form ICL; Lane 9, UV irradiation at 254 nm for 6 min to form reversed single 
strand ODN; Lane 10, UV irradiation at 350 nm for 50 min to form ICL; Lane 11, UV 
irradiation at 254 nm for 6 min to form reversed single strand ODNs. 
 
Figure 22. PAGE analysis of multiple cycles ICL photoreversibility study forduplex-13 
 
Fourcycle photoreversibility study of coumarin-induced ICL of duplex 15- To 
analyze the multiple cycle photoswitchablity, duplex 15 was photoirradiated at 350 nm 
to generate ICL, and the ICL solution was again irradiated by lower wavelength UV light 
254 nm for 6 min to make a cycle. Three more consecutive cycles were completed by 
irradiation repeatedly. The ICL products generated from duplex 15 by 350 nm irradiation 
were  reverted to single stranded ODNs upon 254 nm irradiation, which is similar to 
duplex 10.  
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The reaction mixtures were collected each time and was quenched by an equal volume 
of 90% formamide stop/loading buffer and then electrophoresed on a 20% denaturing 
polyacrylamide gel at 1200 V for approximately 2.5 h. Single-stranded ODN and ICL were 
identified on the basis of their electrophoretic mobility.  
In figure 22; Lane 1, single strand ODN 15a; Lane 2, UV irradiation of duplex 15 at 
350 nm for 50 min to form ICL; Lane 3, UV irradiation at 254 nm for 6 min to cleave the 
ICL product leading to single strand ODN; Lane 4, UV irradiation at 350 nm for 50 min to 
form ICL; Lane 5, UV irradiation at 254 nm for 6 min to form reversed single strand ODN. 
Lane 6; UV irradiation at 350 nm for 50 min to form ICL; Lane 7, UV irradiation at 254 nm 
for 6 min to form reversed single strand ODN; Lane 8, UV irradiation at 350 nm for 50 
min to form ICL; Lane 9, UV irradiation at 254 nm for 6 min to form reversed single 
strand ODN. 
 
 
Figure 23. PAGE analysis of multiple cycles ICL photoreversibility study forduplex-15 
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Fivecycle photoreversibility study of coumarin-induced ICL of duplex12–To 
analyze the multiple cycle photoswitchablity, duplex 12 was photoirradiated at 350 nm 
to generate ICL, and the ICL solution was again irradiated by lover wavelength UV light 
254 nm for 6 min to make a cycle. Four more consecutive cycles were completed by 
irradiation repeatedly. Different from duplex 10, the ICL products generated from 
duplex 12 by 350 nm irradiation were not cleaved to single-stranded ODN upon 254 nm 
irradiation (Figure 24). Therefore the ICLs formed between 1-dA in duplex 12 is not 
reversible upon switching wavelength of UV photoirradiation. 
The reaction mixtures were collected each time and was quenched by an equal 
volume of 90% formamide stop/loading buffer and then electrophoresed on a 20% 
denaturing polyacrylamide gel at 1200 V for approximately 2.5 h. Single-stranded ODN 
and ICL were identified on the basis of their electrophoretic mobility. In figure 24; Lane 
1, single strand ODN 12a; Lane 2, UV irradiation of duplex 12 at 350 nm for 50 min to 
form ICL; Lane 3, UV irradiation at 254 nm for 6 min to cleave the ICL product leading to 
single strand ODN; Lane 4, UV irradiation at 350 nm for 50 min to form ICL; Lane 5, UV 
irradiation at 254 nm for 6 min to form reversed single strand ODN. Lane 6; UV 
irradiation at 350 nm for 50 min to form ICL; Lane 7, UV irradiation at 254 nm for 6 min 
to form reversed single strand ODN; Lane 8, UV irradiation at 350 nm for 50 min to form 
ICL; Lane 9, UV irradiation at 254 nm for 6 min to form reversed single strand ODN; Lane 
10, UV irradiation at 350 nm for 50 min to form ICL; Lane 11, UV irradiation at 254 nm 
for 6 min to form reversed single strand ODNs. 
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Figure 24. PAGE analysis of multiple cycles ICL photoreversibility study forduplex-12 
 
Overal discussion - Multiple cycle photoreversibility analysis (Figures 21, 22, 23, 
and 24) confirmed that the ICL products formed from duplexes 10 and 13 (dT-1, ICL) and 
15 (dC-1, ICL) via 350 nm irradiation were reversible by switching wavelength 350 nm 
and 254 nm photoirradiation while ICL products generated from duplex 12 (dA-1, ICL) 
was not cleaved to single strands by irradiation at 254 nm. 
Selected-ion chromatograms (SICs) for the 10 cycles reversibility study -To further 
substantiate the finding of potential ICl reversibility of dT-1 and dC-1 and non-
reversibility dA-1, Selected-ion chromatograms (SICs) analysis was performed for 10 
cycles reversible reaction of ODN duplexes. The ICLs products of duplex 10 were isolated 
after irradiation at 350 nm (ICL-1), one cycle of 350 nm/254 nm irradiation (ICL-2), and 
those formed after 10 cycles of 350 nm/254 nm irradiation (ICL-20). Then isolated ICL 
products were digested with enzymes to release the ICL as a dinucleoside remnant and 
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subjected the resulting mixture to LC-MS and MS/MS analyses as described above. The 
ratios of area of peaks found were plotted in the SICs for monitoring the loss of a 2-
deoxyribose from the [M+H]+ ions of  dC-1 (as deaminated form,m/z 696  580 
transition), dT-1 (m/z 710  594 transition), and dA-1 adducts (m/z 710  594 
transition) versus that for the [M+H]+ ion of dA (Figure 25). The signals for the dT-1 and 
dU-1 cross-links were decreased from ICL-1 to ICL-2 and ICL-20, whereas a significant 
elevation of dA-1 signal was observed from ICL-1 and ICL-2 to ICL-20. These results 
suggested that the formation of dC-1 and dT-1, but not that of dA-1 is reversible. In this 
context, it is worth noting that, owing to the differences in ionization efficiencies for 
these dinucleosides (dA-1, due to the higher proton affinity of adenine than uracil or 
thymine, is expected to have much better ionization efficiency than dT-1 and dU-1 in the 
positive-ion mode),  
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Figure 25.The ratio of area of peaks for the fragmentations of ICL cleavage 
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3.2.10   Kinetic Study of Photolytic Cleavage for ICL Materials 
Clear indication about degree of reversibility was not found until this experiment 
because the peak area ratios displayed in figure 25 do not reflect the relative levels of 
dT-1, dU-1 and dA-1 ICL formation. Therefore kinetics were studied for the cleavage of 
ICL materials of duplexes 10, 13, 15, and 12 upon UV-irradiation at 254 nm (the rate 
constant was calculated based on disappearance of the ICL prodructs). Cleavage of ICL 
product into two single stranded ODNs were ultrafast and 90% of cleavage were 
completed within 60 s by 254 nm irradiation. However, the kinetic study of cleavage was 
studied over a longer time period. After each time, the irradiation reaction was 
quenched by an equal volume of 90% formamide stop/loading buffer, and then analyzed 
by electrophoresis on a 20% denaturing polyacrylamide gel at 1200 V for approximately 
2.5 h. ICLs have been identified on the basis of their electrophoretic mobility and the 
analysis of the percentage of the ICL cleavage was accomplished.  
Photolytic cleavage of coumarin-induced ICL materials from duplex 10 – Cleavage 
of ICL product of duplex 10 into two single stranded ODNs were investigated. Ultrafast 
cleavage was observed and 90% of ICLs were completely cleaved to single stranded ODN 
within 60 s by 254 nm irradiation. The kinetic study of cleavage was studied over a 
longer time period. The cleavage of coumarin-induced ICL product from duplex 10 into 
two single stranded ODNs upon 254 nm irradiation were analyzed by PAGE (Figures 26 
and 27). 
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Figure 26. PAGE analysis of photolytic cleavage of ICL from duplex-10 
 
 
Lane 1; SS as control, lane 2; ICL as control, lane 3; ICLs were irradiated at 254 nm 
for 2 sec, lane 4; ICLs were irradiated at 254 nm for 5 sec, lane 5;  ICLs were irradiated at 
254 nm for 10 sec, lane 6; ICLs were irradiated at 254 nm for 20 sec, lane 7;  ICLs were 
irradiated at 254 nm for 30 sec, lane 8; ICLs were irradiated at 254 nm for 40 sec, lane 9; 
ICLs were irradiated at 254 nm for 50 sec, lane 10; ICLs were irradiated at 254 nm for 60 
sec, lane 11; ICLs were irradiated at 254 nm for 75 sec, lane 12; ICLs were irradiated at 
254 nm for 90 sec, lane 13; ICLs were irradiated at 254 nm for 120 sec,lane 14; ICLs were 
irradiated at 254 nm for 180 sec. 
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Figure 27.  Photolytic cleavage growth of ICL fromduplex-10 
 
Photolytic cleavage of coumarin-induced ICL materials for duplex 13 - Cleavage of 
ICL product of duplex 13 into two single stranded ODNs were investigated. Similar to the 
ICLs formed with duplex 10, an ultrafast cleavage was observed with 90% of cleavage 
within 60 s upon 254 nm irradiation. The kinetic study of cleavage was studied over a 
longer time period and analyzed by PAGE (Figures 28 and 29). 
ICLs have been identified on the basis of their electrophoretic mobility and the 
analysis of the percentage of the ICL cleavage (Figures 28 and 29). lane 1; SS as control, 
lane 2; ICL as control, lane 3; ICLs were irradiated at 254 nm for 0 sec, lane 4; ICLs was 
irradiated at 254 nm for 2 sec, lane 5; ICLs was irradiated at 254 nm for 5 sec, lane 6; 
ICLs was irradiated at 254 nm for 10 sec, lane 7;  ICLs was irradiated at 254 nm for 20 
sec, lane 8; ICLs was irradiated at 254 nm for 40 sec, lane 9; ICLs was irradiated at 254 
nm for 50 sec, lane 10; ICLs was irradiated at 254 nm for 80 sec, lane 11; ICLs was 
irradiated at 254 nm for 120 sec, lane 12; ICLs was irradiated at 254 nm for 240 sec. 
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Figure 28. PAGE analysis of photolytic cleavage of ICL fromduplex-13 
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Figure 29. Photolytic cleavage growth of ICL fromduplex-13 
 
 
Photolytic cleavage of coumarin-induced ICL materials for duplex 15 - Cleavage 
reaction of ICL products formed from duplex 15 was investigated as well.  The kinetic 
study was studied over a longer time period and analyzed by PAGE analysis. Similar 
results as duplexes 10 and 13 were observed with duplex 15. 90% of ICL products were 
completely cleaved to single stranded ODN within 60 s by 254 nm irradiation.  
63 
 
 
ICLs have been identified on the basis of their electrophoretic mobility and the 
analysis of the percent of ICL cleavage (Figures 30 and 31). lane 1-3; ICL as control; lane 
4-6, ICLs was irradiated at 254 nm for 2 sec, lane 7-9; ICLs was irradiated at 254 nm for 4 
sec, lane 10-12;  ICLs was irradiated at 254 nm for 8 sec, lane 13-15; ICLs was irradiated 
at 254 nm for 15 sec, lane 16-18;  ICLs was irradiated at 254 nm for 30 sec, lane 19-21 ; 
ICLs was irradiated at 254 nm for 60 sec, lane 22-24; ICLs was irradiated at 254 nm for 
120 sec, lane 25-27; ICLs was irradiated at 254 nm for 300 sec 
 
 
 
Figure 30. PAGE analysis of photolytic cleavage of ICL fromduplex-15 
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Figure 31. Photolytic cleavage growth of ICL fromduplex-15 
 
 
Photolytic cleavage of coumarin induced ICL materials for duplex 12 – Different from 
duplexes 10, 13, and 15, the ICL products formed with duplex 12 were stable to 250 nm 
irradiation. No cleavage was observed by irradiation at 250 nm for 15 min (Figure 32 and 
33). 
ICLs have been identified on the basis of their electrophoretic mobility and the 
analysis of the percent of ICL cleavage (Figures 32 and 33). lane 1; SS as control; lane 2; 
ICLs was irradiated at 254 nm for .25 min, lane 3;  ICLs was irradiated at 254 nm for .5 
min, lane 4; ICLs was irradiated at 254 nm for 1 min, lane 5;  ICLs was irradiated at 254 
nm for 2 min, lane 6; ICLs was irradiated at 254 nm for 3 min, lane 7;  ICLs was irradiated 
at 254 nm for 4 min, lane 8; ICLs was irradiated at 254 nm for 5 min, lane 9; ICLs was 
irradiated at 254 nm for 6 min, lane 10; ICLs was irradiated at 254 nm for 7 min, lane 11; 
ICLs was irradiated at 254 nm for 8 min, lane 12; ICLs was irradiated at 254 nm for 12 
min,  lane 13; ICLs was irradiated at 254 nm for 15 min. 
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Figure 32. PAGE analysis of photolytic cleavage of ICL fromduplex-12 
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Figure 33. Photolytic cleavage growth of ICL fromduplex-12 
 
 
Overal discussion - Kinetic study of ICL photo-cleavage also showed that the ICLs 
formed from duplexes 13 (dT-1  cross-linking) and 15 (dC-1 cross-linking) via 350 nm 
irradiation were reversible by 254 nm irradiation, while ICL products generated from 
duplex 12 (dA-1 cross-linking) was not cleaved by irradiation at 254 nm. The photo-
cleavage reaction of the ICL products formed with duplexes 13 and 15 is ultrafast and 
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complete within 90 s and 50 s, respectively (duplex 13: kdT-1-cleave= 5.0 ± 0.9 × 10
-2 s-1, t1/2 = 
13.0 s; duplex 15: kdC-1-cleave= 8.8 ± 0.4 × 10
-2 s-1, t1/2 = 8.0 s). These data was consistent 
with the previous results obtained from LC-MS and MS/MS analysis. 
 
3.3   Experimental Parts  
Materials and methods: 
Unless otherwise specified, all chemicals were purchased from Sigma-Aldrich or 
Fisher Scientific. Water was purified with a Milli-Q purification system. ODNs were 
synthesized via standard automated DNA synthesis techniques using an Applied 
biosystems model 394 instrument. The pac-dA and iPr-Pac-dG phosphoramidites were 
employed for the synthesis of coumarin-dT containing ODNs. 28% NH3 (aq) was used for 
the deprotection of the nucleobases and phosphate moieties at room temperature for 
30 min. ODNs were subjected to 20% denaturing PAGE analysis for purification. The 32P-
labelled ODN (1.0 μM) was annealed with 1.5 equiv. of the complementary strand by 
heating to 65 °C for 3 min in a buffer containing 10 mM potassium phosphate, 100 mM 
NaCl, and pH 7.0 followed by a slow-cooling to room temperature overnight. 
Radiolabeling was carried out according to the standard protocols. -32P-ATP and -32P-
ATP was purchased from Perkin-Elmer Life Sciences. Quantification of radiolabeled 
ODNs was carried out using a Molecular Dynamics Phosphorimager equipped with 
ImageQuant Version 5.2 software. DNA duplexes were irradiated with 350 nm UV light. 
ICL was isolated and analyzed by enzymatic digestion reaction. 
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1H-NMR and 13C-NMR spectra were recorded on Bruker DRX 300 spectrometer 
operating at room temperature. Chemical shifts are reported in parts per million (ppm) 
relative to the residual solvent peak. Multiplicities are reported as singlet (s), doublet 
(d), doublet of doublets (dd), triplet (t) or multiplet (m). Enzymatic digestion of ICL and 
high resolution mass spectrometry were performed at the Department of Chemistry, 
University of California-Riverside. 
Solid-phase syntheses of ODN - The ODNs were synthesized on automated DNA 
synthesizer in a CPG solid supports.  Modified nucleotide 1 at concentration of 154 
mmol L-1 in dry MeCN were coupled and commercial dA, dG, dC, and dT building blocks 
were used as phosphoramidites, which gave a 100% coupling efficiency. 1mL NH3(aq) 
solution was added for base deprotection followed by a 0.5 h occasional shaking and 
later dried. Crude ODNs were purified by gel electrophoresis.  
ODN Synthesis and Characterization - ODNs were synthesized using standard 
solid-phase phosphoramidite chemistry. The coupling efficiency of the incorporation of 
the thieno-dT-containing nucleoside into the ODN was 75%. Purification was 
accomplished by preparative 20% of polyacrylamide gel electrophoresis. To verify the 
integrity and composition of the dT coumarin (1) -containing strand ODN 7a-15a, the 
ODN was analyzed in spectroscopic emission spectrum study and MALDI-TOF analysis. In 
mass analysis, the sequence was determined by the total mass of the DNA molecule 
with coumarin. 
Desaltation of ODN- The largest band of ODN from gel electrophoresis was cut 
out of several bands and then grinded and centrifuged. Centrifuged ODN was used for 
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desaltaion by following procedure. First, the column was activated by running with 
10mL MeCN, 10 mL H2O, and 3mL NH4OAC. Then the centrifuged ODN was slowly ran 
followed by a 30mL H2O and 3mL of MeOH and H2O mixture (3:2). The elute was 
collected into 3x1 small vials and were evaporated in a speed vacuum drier.After 
desaltation, the ODN was dried and the concentration was determined. 
Preparation of DNA cross-linked products for LC-MS analysis - The ICL reactions 
were performed using 10 μM coumarin-containing ODNs, which were annealed with 1.0 
equiv. of the complementary strands by heating to 80 oC for 3 min in a buffer containing 
10 mM pH 7 potassium phosphate buffer and 100 mM NaCl, followed by slowly cooling 
to room temperature overnight. The DNA duplexes were irradiated for 50 min with the 
UV light at 350 nm for the desired time to make sure that the reactions are completed. 
ICL products were isolated by 20% PAGE and Isolated ICLs were treated with a cocktail 
of four enzymes to release the ICL as a dinucleoside remnant and subjected the 
resulting mixture to LC-MS and MS/MS analyses. The instrument was set up for 
monitoring the fragmentation of the dinucleoside remnant of putative ICL products as 
[M+H]+ ions in the positive-ion mode. 
Determination of DNA duplexes’ thermal stability - The melting temperature of 
coumarin containing ODN duplexes were performed by a Varian CARY-100 BIO UV–VIS 
spectrophotometer with the Cary Win UV Thermal program using a 1.0 cm path-length 
cell. All measurements were carried out in 10 mM potassium phosphate buffer (pH 7), 
100 μM ethylenediaminetetraacetic acid (EDTA), and 100 mM NaCl, with 4 μM + 4 μM 
single strand concentration. Samples were heated at 1 °C min−1 from 20 °C to 80 °C and 
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the absorbance of ODN at 260 nm was measured at 1.0 °C steps. At least two 
independent samples have been tested to get the melting temperatures of ODN 
duplexes. 
PAGE analysis of interstrand cross-link formation and kinetic study using 32P-
labelling method - ODNs (0.1 μM)  without coumarin were 5’-32P-labeled and hybridized 
with 1.5 equiv. of the complementary strands in 100 mM NaCl and 10 mM potassium 
phosphate (pH 7). The ODN duplexes were irradiated at 350 nm to form ICLs (a control 
reaction was carried out without photoirradiation). Aliquots were taken at the 
prescribed time and immediately quenched with the equal volume of 95% formamide 
loading buffer, and stored at -20 °C until subjecting to 20% denaturing PAGE analysis. 
For kinetics study, three independent samples were used with the same procedures 
mentioned above. 
G+A sequencing - after separation of ICL product, the reaction mixtures (0.35 μM 
ODN duplex, 20 μL) were co-precipitated with calf thymus DNA (2.5 mg/mL, 5 μL) and 
NaOAc (3 M, 5 μL) in the presence of EtOH (90 μL) at -80oC for 30 min and followed by 
centrifugation for 5 min at 15000rmp. The supernatant was removed, and the pellet was 
washed with cold 75% EtOH and lyophilized for 30 min in a Centrivap Concentrator of 
LABCONCO at 370C. The dried ODN fragments were dissolved in H2O (30 μL) and 
incubated with piperidine (2 M, 10 μL) at 900C for 30 min. The samples were then 
subjected to electrophoresis on a 20% denaturing polyacrylamide gel. 
Hydroxyl radical reaction (Fe (ii) EDTA reaction) - The ICL was purified by 20% 
denaturing PAGE. The band containing cross-linked product was cut, crushed, and 
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eluted with 200 mM NaCl and 20 mM EDTA (2.0 mL). The crude product was further 
purified by C18 column eluting with H2O (3  1.0 mL) followed by MeOH:H2O (3:2, 1.0 
mL). Fe(II)·EDTA cleavage reactions of 32P-labelled oligonucleotide (0.1μM) were 
performed in a buffer containing 50 μM (NH4)2Fe(SO4)2, 100 μM EDTA, 5 mM sodium 
ascorbate, 0.5 M NaCl, 50 mM sodium phosphate (pH 7.0) and 1 mM H2O2 for 3 min at 
room temperature (total substrate volume of 20 μL). It was then quenched with 100 
mM thiourea (10 μL). Samples were lyophilized, dissolved in 20 μL H2O: 90% formamide 
loading buffer (1:1), and subjected to 20% denaturing PAGE analysis. 
Enzymatic digestion of ICL mixture - The isolated ICL products (50 pmol) were 
digested with nuclease P1 (0.5 unit) and phosphodiesterase 2 (0.005 unit) in a buffer (pH 
5.6) containing 30 mM sodium acetate, 1.0 mM zinc acetate, and 1 mM erythro-9-(2-
hydroxy-3-nonyl)adenine (EHNA) at 37°C for 48 h. Alkaline phosphatase (0.5 unit) and 
phosphodiesterase 1 (0.001 unit) were subsequently added to the digestion mixture and 
the reaction continued for 2 h in a 50-mM Tris-HCl buffer (pH 8.9). The enzymes were 
removed by chloroform extraction at the end of enzymatic digestion. The digestion 
products were then analyzed by LC-MS/MS/MS with an Agilent 1200 capillary HPLC 
pump (Agilent Technologies, Santa Clara, CA) and an LTQ linear ion-trap mass 
spectrometer (Thermo Fisher Scientific). A 0.5 × 250 mm Zorbax SB-C18 column (5 μm in 
particle size, Agilent Technologies) was used. A solution of 0.1% (v/v) formic acid in 
water (solution A) and a solution of 0.1% (v/v) formic acid in methanol (solution B) were 
employed as mobile phase at a flow rate of 8.0 μL/min. A gradient of 5 min 0-20% B and 
25 min 20-70% B were used for the separation. The instrument was set up for 
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monitoring the fragmentation of the [M+H]+ ions of putative ICL products in the 
positive-ion mode. 
PAGE analysis of photo-induced (254 nm) cleavage reactions of DNA ICL products 
and kinetic study - The cleavage reactions of ICL product were carried out with 
photoirradiation at 254 nm using two independent samples. Aliquots were taken at the 
prescribed time and immediately quenched with the equal volume of 95% formamide 
loading buffer, and stored at -20 °C until subjecting to 20% denaturing PAGE analysis.  
5-(4-Methylchromen-2-one-1,2,3-triazol-1-yl)methyl-2’-deoxyuridine (1). To a solution 
of7-ethynyl-4-methyl-chromen-2-one (3,200 mg, 1.08 mmol) and 5-azido methyl-2’-
deoxyuridine (2) (270 mg, 0.954 mmol) in MeOH (8 mL), a 0.296 M aqueous solution of 
Na-ascorbate (6 mL) was added followed by a 0.368 M aqueous solution of Cu2SO4 (3.6 
mL). After one hour, TLC confirmed completion of the reaction. The reaction mixture 
was evaporated to dryness and subjected to flash chromatography (DCM/MeOH, 20:1-
7:1) yielding compound 1 (329 mg, 74%) as a white foam. 1H NMR (DMSO-d6, 300 MHz): 
δ 11.60 (s, NH), 8.69 (s, 1H), 8.23 (s, 1H), 7.91-7.90 (d, J = 3 Hz, 1 H), 7.88-7.87 (d, J = 3 
Hz, 1H), 7.82 (s, 1H), 6.39 (s, 1H), 6.19-6.15 (t, J = 12 Hz, 1H), 5.29-5.27 (m, 1H), 5.26 (s, 
2H), 5.06-5.03 (t, J = 9 Hz, 1H), 4.28-4.25 (m, 1H), 3.81-3.80 (d, J = 3Hz, 1H), 3.62-3.56 (d, 
J =18, 2H), 3.33 (s, 3H), 2.19-2.15 (t, J = 12Hz, 2H): 13C NMR (DMSO-d6, 300 MHz):δ 
163.05, 160.23, 153.98, 153.50, 150.74, 145.07, 141.89, 134.77, 126.59, 123.17, 121.43, 
119.45, 114.51, 112.75, 107.52, 88.04, 85.02, 70.62, 61.64, 47.03, 22.98, 18.52; MALDI-
MS [MH+] calcd. for C22H21N5O7, 468.1519; found, 468.1515. 
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5'-O-(4,4'-Dimethoxytriphenylmethyl)-5-(4-methylchromen-2-one-1,2,3-triazol-
1-yl)methyl-2’-deoxyuridine (4). Compound 1 (0.3 g, 0.64 mmol) was co-evaporated 
with anhydrous pyridine (3×5 mL) and then dissolved in pyridine (5 mL). To the solution, 
4, 4'-dimethoxytriphenylmethyl chloride (0.304 g, 0.90 mmol) was added in two 
portions and the reaction mixture was stirred at r. t. for 8 h. The reaction was quenched 
by addition of MeOH and was concentrated in vacuo. The crude product was purified by 
flash chromatography (CH2Cl2/MeOH/Et3N = 96/3/1) to give 4 (0.345 g, 68%) as a off-
white solid. 1H NMR (CDCl3, 300 MHz): δ 7.92-7.60 (m, 4H), 7.47-6.87 (m, 15H), 6.47-
6.43 (t, J = 12 Hz, 1H), 4.83 (s, 2H), 4.43-4.38 (t, J = 15 Hz, 1H), 4.18-4.17 (d, J = 3 Hz, 1H), 
4.15-4.01 (s, 3H), 3.48-4.39 (m, J = 27 Hz, 1H), 2.74 (s, 6H), 2.72-2.67 (d, J = 15 Hz, 2H), 
2.44-2.38 (t, J = 18 Hz, 2H): 13C NMR (CDCl3, 300 MHz): δ 164.58, 161.45, 158.76,158.73, 
153.85, 152.88, 149.92, 145.96, 144.50, 141.54, 135.47, 135.23, 134.70, 130.25, 130.15, 
128.17, 128.15, 127.18, 124.99, 122.29, 121.68, 119.30, 114.49, 113.91, 113.44, 108.18, 
87.08, 86.89, 85.96, 77.47, 77.25, 76.62, 72.29, 63.62, 55.27, 46.18, 46.06, 42.18, 29.70, 
18.66, 10.67, 1.02; MALDI-MS [MNa+] calcd. for C43H39N5O9, 792.2645; found, 792.2624. 
5'-O-(4,4'-Dimethoxytriphenylmethyl)-5-(4-methylchromen-2-one-1,2,3-triazol-
1-yl)methyl-2’-deoxyuridine-3'-(2-cyanoethyl)-N, N-diisopropylphosphoramidite 
(4a).Compound 4 (0.2 g, 0.25 mmol) was dissolved in anhydrous CH2Cl2 (5 mL) under Ar 
atmosphere. Diisopropylethylamine (96 μL, 0.55 mmol) and 2-cyanoethyl-N,N-
diisopropylchlorophosphoramidite (96 μL, 0.43 mmol) was added. The reaction mixture 
was stirred at r.t. for 30 min, diluted with CH2Cl2 (30 mL), washed with 5% aqueous 
NaHCO3 solution, followed by brine. The organic solution was dried over anhydrous 
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Na2SO4, filtered, and concentrated. The residue was submitted to flash chromatography 
(EtOAc/CH2Cl2/Et3N = 66/33/1) to yield product 4a (0.200 g, 80%) as a white foam. 
31P 
NMR (CDCl3, 300 MHz): δ 150.0, 150.2. 
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Chapter 4 
 
Synthesis of Coumarin-Modified 2’-Deoxycytosine (dC) and 2’-
Deoxyadenosine (dA) by “Click” Chemistry 
 
4.1   Background 
Modification of nucleosides are extremely important for versatile fields of 
medicinal chemistry and chemical biology research. The “click” reaction is very useful for 
conjugating or functionalizing the nucleotide molecule under mild conditions and has 
wide applications in the emerging field of cell biology and functional proteomics. The 
enhancement of fluorescent properties within purine and pyrimidine nucleoside 
scaffolds is extremely important and versatile, and has wide biological applications. 
Many intense research work was done to discover fluorescent base analogs using 
stilbene, terphenyl, pyrene, phenanthrene, terthiophene, and benzoterthiophene [162]. 
Some groups have replaced the natural base with coumarin dye [136, 164], tethered 
stilbene [165], and pteridine dyes [166] which exhibit the aforementioned fluorescent 
moiety. Fluorophores also have been widely studied and reviewed for labeling of DNA 
[167-172].  
Still there is a need for development and synthesis of newly modified florescent 
nucleosides that can act as novel analogs and act as precisely advantageous reporter 
probes with other exceptional biological properties in the ODN environment.  Here, we 
performed an extended conjugation of coumarin to dA and dC. Cu-mediated azide-
alkyne “click” reaction was undertaken smoothly between alkyne modified coumarin 
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derivative 3 and the azide modified dC and dA with excellent yields to form compounds 
10 and 11. 
 
4.2 Results and discussion 
4.2.1 Synthesis of Coumarin-Containing dA (10) 
On behalf of conjugation of coumarin at the 6-position of dA via a triazole, “click” 
chemistry procedure was followed after modification of dA with azide. Initially two 
different routes were employed depending on protection of extremely nucleophilic 3’ 
and 5’OH functional groups for the modification reactions; (i) introduction of base labile 
acetate-protecting group at the 3’- and 5’- OH groupof dA precursor then conversion to 
coumarin-conjugated dA (Scheme 10 and Figure 34) and (ii) introduction of acid labile 
sillyl group at the 3’- and 5’- OH group of dA precursor then conversion to coumarin-
conjugated dA (Scheme 11 and 12) 
Synthesis of 6-azido-3’, 5’-di-O-(tert-butyldimethylsilyl)-9-[2-deoxy-β-D-ribofuranosyl] 
adenosine (10h) – For the first route synthesis, dA was used as a starting material. 
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Deamination reaction was taken place with NaNO2 in glacial acetic acid to form 10a, 
product 10a was used for acetate protection reaction with acetic anhydride in pyridine 
solution giving 10f following the known procedure [350](Scheme 10). Compound 10f 
was reacted with (Benzotriazol-1-yloxy)tris(dimethylamino)phosphonium 
hexafluorophosphate (BOP) under the catalysis of (iPr)2NEt in anhydrous CH2Cl2to give 
10g with 94% yield. Subsequent reaction with sodium azide in anhydrous DMSO results 
acetate-protected azide modified dA (10h) with 92% yield (Scheme 10).  Similar NMR of 
10h was found to previously published NMR of same compound [350].  
Scheme 10.  Synthesis of azide modified dA 
“Click” reaction and deprotection of acetate group -The next stage involved the 
azide-alkyne ligation reaction of coumarin using the optimized conditions of “click” 
reaction (CuSO4/Na-ascorbate in CH2Cl2/H2O). Successful ligation was taken place by 
“click” reaction of coumarin 7-Ethynyl-4-methyl-chromen-2-one (3) and10h to form 10i 
in 76% yield. Deprotection reaction of compound 10i was run with aqueous NH3 in 
dioxane solution. The deprotection reaction did not go well and desired product was not 
obtained. Compound 10 was decomposed after three days as shown in TLC (Figure 34). 
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Figure 34.  Synthesis of coumarin modified dA 
 
Synthesis of 6-Azido-3’,5’-Di-O-(tert-butyldimethylsilyl)-9-[2-deoxy-β-D-
ribofuranosyl] adenosine (10d) - Since basic condition for acetate deprotection was not 
compatible with coumarin-modified dA, we switched to the second route where  dA was 
protected at the 3’- and 5’-OH functional group with sillyl group. First, the sillyl 
protection reaction was run with previously synthesized deaminated dA (10a) which 
reacted with tert-butyldimethylsilyl chloride (TBAF) in the presence of imidazole in dry 
DMF solution giving 10b (Scheme 11) with 76% yield. Compound 10b then reacted with 
BOP under the catalysis of (iPr)2NEt in anhydrous CH2Cl2 to form 76% of 10c. Subsequent 
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reaction with sodium azide in anhydrous DMSO resulted in azide-modified adenine with 
sillyl-protected dA (10d) with 80% yield (Scheme 11).  
  
Scheme 11. Synthesis of azide-modified dA 
Synthesis of 6-(4-methylchromen-2-one-1,2,3-triazol-1-yl)-9-[2-deoxy-β-D-
ribofuranosyl]purine (10) - The next step involved the azide-alkyne “click” conjugation 
reaction using the optimized conditions (CuSO4/Na-ascorbate in CH2Cl2/H2O). Successful 
conjugation was taken place between presynthesized 7-ethynyl-4-methyl-chromen-2-
one (3) and 10d to form 10e. Deprotection reaction of silyl group in compound 10e was 
run without separation with TBAF in MeOH solution. The deprotection reaction went 
very well and the desired deprotected coumarin-conjugated dA, 6-(4-methylchromen-2-
one-1,2,3-triazol-1-yl)-9-[2-deoxy-β-D-ribofuranosyl]adenosine (10) was accomplished 
with 65% yield in two steps. 
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Scheme 12. Synthesis of coumarin-modified dA 
 
4.2.2 Synthesis of Coumarin-Containing dC (11) 
To synthesize 11, the optimized conditions of “click” reaction were used with sodium 
ascorbate and copper sulphate in water and dichloromethane solution. Successful 
coumarin ligation was performed via the reaction between previously synthesized 
precursor 7-ethynyl-4-methyl-chromen-2-one (3) and azide-modified dT (11a) to yield 
11b in a good yield (77%). Compound 11b and 1,2,4-triazole were suspended in 
anhydrous CH3CN and Et3N and phosphorous oxytrichloride (2.2 mL, 24.0 mmol) was 
added. The reaction mixture was stirred at r.t. for one hour and compound 11c was 
formed with 73% yield. Subsequently, deprotection reaction of 11c was taken place with 
NH3 (Aq) in MeOH solution to produce coumarin-modified deprotected nucleoside 5-(4-
methylchromen-2-one-1,2,3-triazol-1-yl)methyl-2’-deoxycytosine (11) with 65% yield 
(Scheme 13). 
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Scheme 13. Synthesis of coumarin-modified dC 
 
4.3   Experimental parts.  
 
3’,5’-Di-O-acetyl-O6-(benzotriazol-1-yl)-2’-deoxyinosine (10g). In a clean, dry 
100 mL round-bottom flask equipped with a stirring bar, placed 2’-deoxyinosine 3’,5’-
diacetate 10f (300 mg, 0.893 mmol) and BOP (790 mg, 1.79 mmol) in anhydrous CH2Cl2 
(8.0 mL). To this stirred mixture, (i-Pr)2NEt3 (0.31 mL, 1.79 mmol) was added, and the 
stirring was continued at room temperature for 22 h. The mixture was evaporated to 
dryness, and the residue was redissolved in EtOAc. The mixture was washed with water 
and then with brine. The organic layer was dried over Na2SO4 and concentrated under 
reduced pressure. The crude product was purified by column chromatography on silica 
gel using EtOAc/hexanes (1:5-1:3) to provide 10g as a white foamy solid (382 mg, 94% 
yield). 1HNMR (300MHz, CDCl3) is similar to those described in ref [350] 
81 
 
 
6-Azido-3’5’-Di-O-acetyl-O6-(benzotriazol-1-yl)-2’-deoxyinosine (10h). In a 
clean, dry vial equipped with a stirring bar were placed 10g (249mg, 0.550 mmol) and 
NaN3(107 g, 1.65 mmol) in DMSO (2.5mL). The mixture was flushed with nitrogen gas 
and stirred at room temperature for 1 h at which time TLC indicated the reaction to be 
complete. The mixture was diluted with EtOAc and transferred to a separatory funnel. 
The mixture was extracted with 1:1 water-brine (3x), water (3x), and finally once with 
brine. The organic layer was dried over Na2SO4 and evaporated under reduced pressure. 
Chromatography of the crude material on a silica gel column using EtOAc/hexanes (1:5-
1:3) afforded a white foamy material 10h(182 mg, 92% yield): 1HNMR(300MHz, CDCl3) is 
similar to those described in ref [350] 
6-Azido-(4-methylchromen-2-one-1,2,3-triazol-1-yl)-3’5’-Di-O-acetyl-O6-
(benzotriazol-1-yl)-2’-deoxyinosine (10i). To a solution of6-Azido-3’5’-Di-O-acetyl-O6-
(benzotriazol-1-yl)-2’-deoxyinosine 10h (390 mg, 1.08 mmol) and compound 3 (175 mg, 
0.954 mmol) in DCM (8 mL), a 0.296 M aqueous solution of Na-ascorbate (6 mL) was 
added followed by a 0.368 M aqueous solution of Cu2SO4 (3.6 mL). After one hour, TLC 
confirmed completion of the reaction. The reaction mixture was evaporated to dryness 
and subjected to flash chromatography (DCM/MeOH, 20:1-7:1) yieldingwhite foamy 
material 10i (451 mg, 76% yield): 1H NMR (300 MHz, CDCl3): δ 9.36 (s, 1H), 9.17 (s, 1H), 
8.57 (s, 1H), 8.17-8.11 (d,J=18, 1H), 8.87 (s, 1H), 8.77-8.73 (d,J= 12, 1H), 7.37 (s, 1H), 
6.61-6.59 (t,J= 6.0 Hz, 1H), 5.50-5.41 (m, 1H), 4.37-4.29 (m, 2H), 2.94-2.86 (m, 1H), 2.54-
2.50 (s, 2H), 2.40 (s, 3H), 2.11 and 2.01 (2s, 6H). 13C NMR (300MHz, CDCl3):δ 170.1, 
160.0,  253.1, 152.2, 151.9, 151.5, 148.0, 147.5, 147.3, 145.4, 133.8, 126.1, 125.6, 125.2, 
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124.1, 120.3, 121.2, 115.0, 116.1, 84.4, 83.1, 73.0, 63.4, 39.1, 19.8, 18.5.MALDI-ESI 
[MH+] calcd. for C22H21N5O7, 446.17; found, 446.17. 
3’,5’-O-Bis(tert-butyldimethylsilyl)-2’-deoxyinosine (10b). Compound 10a (252 
mg, 1 mmol) was rendered by repeated co-evaporation with dry pyridine (3 times) and 
dry toluene (3 times) and dissolved in DMF (10 mL). To the solution were added 
imidazole (335 mg, 5 mmol) and tert-butyldimethylsilyl chloride (362 mg, 2.4 mmol). 
After being stirred at room temperature for 3 h, the solution was diluted with CHCl3 (80 
mL), and the mixture was washed three times with saturated NaHCO3. The organic layer 
was collected, dried over Na2SO4, filtered, and evaporated under reduced pressure. The 
crude product was purified by silica gel chromatography with 80% EtOAc in hexanes to 
give the product 10b (363 mg, 76%): 1HNMR(300MHz, CDCl3) is similar to those 
described in ref [350] 
3’,5’-O-Bis(tert-butyldimethylsilyl)--O6-(benzotriazol-1-yl)-2’-deoxyinosine 
(10c). In a clean, dry vial equipped with a stirring bar were placed10b (300 g, 0.625 
mmol), BOP (673 mg, 1.52 mmol), anhydrous CH2Cl2 (8.0mL), and (i-Pr)2NEt (0.26 mL, 
1.52 mmol). The crude product was purified by column chromatography on silica 
gelusing 40% EtOAc in hexane to provide 10casawhite foamy solid (283 mg, 76% yield). 
1HNMR(300MHz, CDCl3) is similar to those described in ref [350] 
6-Azido-9-[2-deoxy-3,5-di-O-(tert-butyldimethylsilyl)-β-D-ribofuranosyl]purine 
(10d). In a clean, dry 50 mL round-bottomed flask equipped with a stirring bar were 
placed O6-(benzotriazol-1-yl)-2’,3’-di-O-(tert-butyldimethylsilyl)-2’-deoxyinosine (10c) 
(1.036 g, 1.73 mmol) and NaN3(326 mg, 5.0 mmol) in anhydrous DMSO (8.6 mL). The 
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reaction mixture was transferred to a separatory funnel and partitioned between EtOAc 
and a 1:1 mixture of water-brine. The organic layer was washed with 1:1 water-brine 
mixture, then with water, and finally with brine. The organic layer was dried over 
Na2SO4 and evaporated under reduced pressure. Filtration of the crude material 
through a silica gel plug using 20% EtOAc in hexanes solution afforded 10d as a clear 
gum (700 mg, 80%). 1HNMR (300MHz, CDCl3) is similar to those described in ref [350] 
Synthesis of 6-(4-methylchromen-2-one-1,2,3-triazol-1-yl]-9-(2’-deoxy-β-D-
ribofuranosyl)purine (10). To a solution of 7-ethynyl-4-methyl-chromen-2-one (3, 200 
mg, 1.08 mmol) and 10d (270 mg, 0.534 mmol) in MeOH (8 mL), a 0.296 M aqueous 
solution of Na-ascorbate (6 mL) was added followed by a 0.368 M aqueous solution of 
Cu2SO4 (3.6 mL). After one hour, TLC confirmed completion of the reaction. The reaction 
mixture of nucleoside derivative 10e was evaporated to dryness and dissolved in 
methanol (25 mL) and tetrabutylammomium fluoride (4 mL 1.0 M solution in THF, 
4.0mmol) was added to the solution. The reaction mixture was stirred at 60°C for 3 
hours for complete deprotection reaction of silyl group. After cooling to room 
temperature, the crude product was evaporated and purified on silica gel 
(DCM:MeOH=5:1) to obtain 10 as a white solid (0.35 mmol, 65 % yield in two steps).  
1H NMR (300 MHz, DMSO-d6): δ 9.36 (s, 1H), 9.17 (s, 1H), 8.57 (s, 1H), 8.17-8.11 (d,J=18, 
1H), 8.87 (s, 1H), 8.77-8.73 (d,J= 12, 1H), 7.37 (s, 1H), 6.61-6.59 (t,J= 6.0 Hz, 1H), 5.50-
5.41 (m, 1H), 4.37-4.29 (m, 2H), 2.94-2.86 (m, 1H), 2.54-2.50 (s, 2H), 2.40 (s, 3H), 2.11 
and 2.01 (2s, 6H). 13C NMR (300MHz, CDCl3):δ 170.1, 160.0,  253.1, 152.2, 151.9, 151.5, 
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148.0, 147.5, 147.3, 145.4, 133.8, 126.1, 125.6, 124.1, 120.3, 121.2, 115.0, 116.1, 84.4, 
83.1, 73.0, 63.4, 39.1, 20.91, 19.8, 18.5. 
5-(4-methylchromen-2-one-1,2,3-triazol-1-yl)methyl-2’-deoxyuridine (11b). To 
a solution of 7-ethynyl-4-methyl-chromen-2-one (3, 200 mg, 1.08 mmol) and 5-azido-
methyl-2’-deoxyuridine (11a) (350 mg, 0.954 mmol) in MeOH (8 mL), a 0.296 M aqueous 
solution of Na-ascorbate (6 mL) was added followed by a 0.368 M aqueous solution of 
Cu2SO4 (3.6 mL). After one hour, TLC confirmed completion of the reaction. The reaction 
mixture was evaporated to dryness and subjected to flash chromatography 
(DCM/MeOH, 20:1-7:1) yielding compound 11b (405 mg, 77%) as a white foam.1H NMR 
(CDCl3, 300 MHz): δ 8.29 (s, 1H), 7.95 (s, 1H), 7.85-7.80 (d, J = 3 Hz, 1 H), 7.76 (s, 1H), 
7.58-7.57 (d, J = 3 Hz, 1H), 7.56 (s, 1H), 7.54 (s, 1H), 6.39 (s, 1H), 6.19-6.15 (t, J = 12 Hz, 
1H), 5.29-5.27 (m, 1H), 5.26 (s, 2H), 5.06-5.03 (t, J = 9 Hz, 1H), 4.28-4.25 (m, 1H), 3.81-
3.80 (d, J = 3Hz, 1H), 3.62-3.56 (d, J =18, 2H), 3.33 (s, 3H), 2.19-2.15 (t, J = 12Hz, 2H), 
2.11 and 2.01 (2s, 6H). 
3’,5’-bis-O-Acetyl-5-(4-methylchromen-2-one-1,2,3-triazol-1-yl)methyl-N4-
triazoyl-2’-deoxyuridine (11c). Compound 11b (2.80g, 5.2 mmol) and 1,2,4-triazole 
(7.25 g, 0.105 mol) were suspended in anhydrous CH3CN (50 mL). Et3N (16 mL) and 
phosphorous oxytrichloride (2.2 mL, 24.0 mmol) were added. The reaction mixture was 
stirred at r.t. for one hour, diluted with ethyl acetate (100 mL) and washed with 
saturated NaHCO3 and brine. The organic solution was dried over anhydrous Na2SO4, 
concentrated and the residue was submitted to flash chromatography (column 6 × 12 
cm, EtOAC/Hexanes, 1:1 →4:1) yielding a colorless foam 11c (2.3 g, 73 %). 1H NMR 
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(CDCl3, 300 MHz): δ 8.21 (s, 1H), 8.19 (s, 1H), 7.85-7.80 (d, J = 3 Hz, 1 H), 8.79 (s, 1H), 
7.58-7.57 (d, J = 3 Hz, 1H), 7.56 (s, 1H), 7.82 (s, 1H), 6.39 (s, 1H), 6.19-6.15 (t, J = 12 Hz, 
1H), 5.29-5.27 (m, 1H), 5.26 (s, 2H), 5.06-5.03 (t, J = 9 Hz, 1H), 4.28-4.25 (m, 1H), 3.81-
3.80 (d, J = 3Hz, 1H), 3.62-3.56 (d, J =18, 2H), 3.33 (s, 3H), 2.19-2.15 (t, J = 12Hz, 2H), 
2.11 and 2.01 (2s, 6H): 13C NMR (DMSO-d6, 300 MHz):δ 170.6, 170.1, 163.05, 160.23, 
153.98, 155.0, 154.1, 153.50, 152.74, 145.07, 141.89, 134.77, 126.59, 123.17, 121.43, 
119.45, 114.51, 112.75, 99.52, 88.04, 85.02, 70.62, 61.64, 47.03, 36.98, 21.3, 21.4, 18.52 
5-(4-methylchromen-2-one-1,2,3-triazol-1-yl)methyl-2’-deoxycytidine (11). Compound 
11c (2.2 g, 3.65 mmol) was dissolved in dioxane (45 mL). Aqueous NH3 (28%, 45 mL) was 
added and the reaction mixture was stirred at r.t. overnight. After evaporation, the 
residue was subjected to flash chromatography (column 6 × 12 cm, CH2Cl2/MeOH, 9:1 → 
4:1). The fractions containing the desired material were collected and evaporated to 
dryness to give 11 as colorless solid (1.12 g, 87%). 1H NMR (DMSO-d6, 300 MHz): δ 8.70 
(s, NH2), 8.11 (s, 1H), 7.90 (s, 1H), 7.85-7.80 (d, J = 3 Hz, 1 H), 7.88-7.87 (d, J = 3 Hz, 1H), 
7.82 (s, 1H), 6.39 (s, 1H), 6.19-6.15 (t, J = 12 Hz, 1H), 5.29-5.27 (m, 1H), 5.26 (s, 2H), 5.06-
5.03 (t, J = 9 Hz, 1H), 4.28-4.25 (m, 1H), 3.81-3.80 (d, J = 3Hz, 1H), 3.62-3.56 (d, J =18, 
2H), 3.33 (s, 3H), 2.19-2.15 (t, J = 12Hz, 2H): 13C NMR (DMSO-d6, 300 MHz):δ 163.05, 
160.23, 153.98, 153.50, 152.74, 145.07, 141.89, 134.77, 126.59, 123.17, 121.43, 119.45, 
114.51, 112.75, 99.52, 88.04, 85.02, 70.62, 61.64, 47.03, 22.98, 18.52; MALDI-MS [MH+] 
calcd. for C22H22N6O6, 467.1667; found, 467.1667. 
86 
 
 
Chapter 5 
 
Modified 2’-Deoxythymidine (dT) and Oligodeoxynucleotide 
(ODN) Containing Triazole and Phenyl Triazole: Synthesis and 
Properties 
 
5.1 Background 
 
Among the broad range of heterocyclic molecule, triazole is an ideal molecule 
and great attraction for researchers. Significant amount of research have shown that the 
triazole and its derivatives have strong effect on anti-antiviral anti-HIV, antibacterial 
[143], antitubercular [174], anti-allergenic, antimicrobial, cytostatic, virostatic, anti-
inflamatory, anti-bacterial activities, antifungal [175-177], and antitumor [178] activities. 
Moreover they have been used as herbicides, light stabilizers, fluorescent whiteners, 
optical brightening agents, pigments, and corrosion retardants. However, there is 
currently no significant research involving the photo-physical activities of triazole 
heterocycles with pyrimidine in nucleic acids. Considering the broad spectrum of 
activities that triazole exhibit; 1,2,3-triazole and phenyl substituted 1,2,3-triazole was 
conjugated with dT and their photophysical property in DNA was investigatedas they 
might change the microenvironment of the DNA duplex and significantly alter the 
biological properties relative to a bare DNA. 
In this research, 1,2,3-triazole- and 4-phenyl-1,2,3-triazole-conjugated dT (5 and 
6) were respectively obtained by using the CuAAC (Cu-catalyzed alkyn-azide 
cycloaddition) “click” reaction and were introduced into the ODN after making the 
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appropriate phosphoramidite building blocks (5d and 6d) in only a few synthetic steps. 
Stability and photophysical characteristics were analyzed.  
 
Scheme 15. Structures of modified dT (5-6). 
 
5.2   Results and Discussion 
5.2.1   Synthesis of Triazole-Conjugated dT (5) 
In order to investigate the photophysical properties of triazole-conjugated 
pyrimidine nucleosides in DNA, 1,2,3-triazole conjugated dT (5) was designed and 
synthesized. To accomplish compound 5, “click” reaction was performed between 
trimethylsilylacetylene and 3’,5’-bis-O-acetyl-5-azedomethyl-2’-deoxyuridine (11a) 
under the catalysis of sodium ascorbate and copper sulphate in water solution, the 
reaction took place successfully to produce compound 5a with a 74% yield. Then two 
consecutive deprotection reactions were performed with TBAF in MeOH solution and 
25% of NH3(aq) in MeOH solution without separation in between, yielding triazole 
conjugated compound 5-(1,2,3-triazol-1-yl)methyl-2’-deoxyuridine (5) with a 60% yield 
in two steps (Scheme 16). 
88 
 
 
 
Scheme 16.  Synthesis of 1,2,3-triazole-modified dT 
 
Synthesis of phosphoramidite derived from 5 – Phosphoramidite 5d was 
synthesized to accomplish the incorporation of compound 5 in ODN by automated DNA 
solid phase synthesis. At first, the DMT residue was introduced in 5’-OH functional 
group of  compound 5 with 68% yield by reacting with DMTCl in anhydrous pyridine 
solution. The DMT-derivative 5c was converted into the phonphoramidite building block 
5d with 77% yield by phosphitylation under the Ar atmosphere reacting with 
diisopropylethylamine and 2-cyanoethyl-N,N-diisopropylchlorophosphoramidite 
(Scheme 17). 
89 
 
 
 
Scheme 17. Synthesis of phosphoramidite derived from 5 
 
5.2.2 Modified ODN Containing 5: Synthesis and Properties 
5.2.2.1 Synthesis of Modified ODN Containing 5 
The purpose of this project was to study the photophysical properties of triazole 
in ODN. Therefore, triazole-modified dT 5 was incorporated in ODN 107 by solid phase 
synthesis using the phosphoramidite chemistry protocol (Table 5). The ODN was purified 
by 20% PAGE analysis and confirmed by MALDI mass analysis.  After quantification of 
synthesized ODN, radiolabeling was carried out according to the standard protocols with 
[γ-32P] ATP. Modified [γ-32P]ATP-labelled ODN107 was hybridized to form duplex 20 with 
presynthesized complementary ODN 6b by mixing 1.5 equiv from 650C to room 
temperature in a buffer of potassium phosphate, pH 7.0, and 1M NaCl, followed by slow-
cooling to room temperature overnight. 
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Table 5. Synthesized ODNs and duplexes 
ID Sequence 
ODN-107 
 
ODN-6b 
 
Duplex-6 
 
Duplex-20 
 
 
5.2.2.2 ICL Study with Triazole-modified dT 
The modified ODN duplex 20 and previously synthesized non-modified ODN 
duplex 6 were photo-irradiated at 350 nm for 2 hours using a Rayonet Photochemical 
Chamber Reactor (Model RPR-100) as the wavelength of 350 nm is compatible with 
biological molecules. The UV-irradiation of duplex 20 resulted in a new band. The new 
band showed that the modified nucleoside 5 was covalently bound with the 
complementary strand strand leading the formation of ICL (Figure 35). Further reaction 
analysis in different pH showed that the highest ICL yield was observed under the acidic 
conditions at pH-5  (Table 6). 
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Figure 35.   PAGE analysis ofICL formation for duplex 6 and duplex 20 
 
 
Table 6.  Percentage of ICL formation under variable pH for duplex 20 
 
pH 5 6 7 8 9 
ODN Duplex % of ICL % of ICL % of ICL % of ICL % of ICL 
Duplex-6 0 0 0 0 0 
Duplex-20 1.5 0.4 0.8 1 .1 1.2 
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5.2.3 Synthesis of Phenyl-triazole-Conjugated dT (6)  
To accomplish phenyl-substituted triazole modified dT (6), we first performed a 
“click” reaction between  phenylalkyne- group and 5-azedomethyl-2’-deoxyuridine (2) 
with the catalysis of sodium ascorbate and copper sulphate in water and methanol 
solution, the reaction took place successfully to produce compound 6 with 74% yield. 
For solid phase synthesis of ODN containing compound 6, the corresponding 
phosphoramidite 6d was prepared. The DMT residue was introduced at the 5’-OH 
functional group of compound 6. The reaction went well in pyridine solution with 68% 
yield of 6c. The DMT derivative 6c was converted into the phonphoramidite 6d in 78% 
yield by phosphitylation under Ar atmosphere reacting with diisopropylethylamine and 
2-cyanoethyl-N,N-diisopropylchlorophosphoramidite (Scheme 18). 
 
 
Scheme 18. Synthesis of the phosphoramidite 6d derived from 6.  
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5.2.4 Modified-ODN Containing 6: Synthesis and Properties 
5.2.4.1 Synthesis of Modified-ODN Containing 6 
The purpose of this project was to study the photophysical properties of phenyl-
triazole in DNA. Therefore, phenyl-triazole-modified dT (6) was incorporated in ODN 15 
by solid phase synthesis using the phosphoramidite chemistry protocol (Table 7). The 
ODN was purified by 20% PAGE analysis and confirmed by MALDI mass analysis.  After 
quantification of synthesized ODN, radiolabeling was carried out according to the 
standard protocols with [γ-32P]ATP. Modified [γ-32P]ATP-labelled ODN 15 was hybridized 
to form duplex 21 with presynthesized complement ODN 6b by mixing 1.5 equiv. from 
650C to room temperature in a buffer of potassium phosphate, pH 7.0, and 1M NaCl, 
followed by slow-cooling to room temperature overnight. 
 
Table 7. Synthesized ODNs and duplexes 
ID Sequence 
ODN-15 
 
ODN-6b 
 
Duplex-6 
 
Duplex-21 
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5.2.4.2 ICL Study with Phenyl-triazole Modified dT 
The modified ODN duplex 21 and previously synthesized non-modified ODN 
duplex 6 were photo-irradiated at 350 nm. The UV-irradiation of duplex 21 resulted in a 
new band. The new band showed that the modified nucleoside 6 was covalently binded 
with the complementary strand leading to the formation of the ICLs (Figure 36). Further 
reaction analysis in different pH showed that the highest ICL yield was observed under 
the acidic conditions at pH-5 (Table 8). 
 
 
Figure 36.   PAGE analysis of the ICL formation with duplex 6 and duplex 21. 
 
 
Table 8. Percentage of ICL formation under variable pH with duplex 21 
pH 6 7 8 8 
ODN Duplex % of ICL % of ICL % of ICL % of ICL 
Duplex-6 0 0 0 0 
Duplex-21 2.5 0.2 10.1 2.0 
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5.2.5 Melting Temperature (MT) Study of the Modified ODNs 
 
 
Scheme 19 
 
To explore whether the modified ODN duplex can be utilized for ODN 
hybridization,  the thermal denaturation experiments were conducted. It is important to 
note that the basic condition has a relatively higher constructive effect on duplex 
stability as determined by thermal denaturation measurements. The highest melting 
point (Tm)  was observed  at pH 8 while the lowest Tm was found at pH 5. This result  
indicated that the most stable duplex DNA was formed at a higher pH while the least 
stable one is formed at a lower pH. 
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Table 9. Melting temperature (Tm) study of the modified ODN duplexes 
 pH values  pH=5 pH=6 pH=7 pH=8 
Melting Temperature (Tm) 
0C 0C 0C 0C 
Duplex-7 48.05 52.30 53.92 57.26 
Duplex-20 47.24 50.87 51.40 56.70 
 
5.3   Experimental Part 
 
5-(1,2,3-Triazol-1-yl)methyl-2’-deoxyuridine (5a). To a solution of 11a (395 mg, 
1.08 mmol) and Trimethylsilylacetylene (118 mg, 1.20 mmol) in DCM (8 mL), a 0.296 M 
aqueous solution of Na-ascorbate (6 mL) was added, followed by a 0.368 M aqueous 
solution of Cu2SO4 (3.6 mL). After one hour, TLC confirmed completion of the reaction. 
The reaction mixture was evaporated to dryness and subjected to flash chromatography 
(DCM/MeOH, 10:1-7:1) yielding compound 5a (365 mg, 74%) as a white foam. 1H NMR 
(CDCl3, 300 MHz): δ9.5 (s, 1H), 7.89 (s, 1H), 7.79 (s, 1H), 6.20 (t, 1H, J= 6.4 Hz), 5.25 (d, 
1H, J= 4.4 Hz),5.20 (s, 1H),5.19 (t, 1H, J= 4.8 Hz), 3.83 (q, 1H, J= 3.6 Hz), 3.72-3.58 (m, 
2H), 2.23 (m, 1H), 2.20 (m, 1H), 2.10 (s, s, 6H), 0.51 (s, s, s, 9H): 13C NMR (CDCl3, 300 
MHz):δ171.2, 163.05, 150.23, 148.98, 140.50, 130.74, 110.07, 85.89, 82.77, 77.9, 77.5, 
76.1,  73.59, 45.17, 38.43, 20.1, 5.2, 1.1, 0.8.  
5-(1,2,3-Triazol-1-yl)methyl-2’-deoxyuridine (5). Compound 5a (300 mg, 0.645 
mmol) was dissolved in methanol (25 mL) and tetrabutylammomium fluoride (4.5 mL 
1.0 M solution in THF, 4.0 mmol) was added in the solution. The reaction mixture was 
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stirred at 60°C for 3 hours for complete deprotection of the silyl group. After cooling to 
room temperature, the crude product was evaporated and aqueous NH3 (28%, 50 mL) 
was added without further separation and the reaction mixture was stirred at r.t. 
overnight. After evaporation, the residue was subjected to flash chromatography 
(DCM/MeOH, 20:1-7:1) yielding compound 5 (120 mg, 60%) as a white foam. 1H NMR 
(DMSO-d6, 300 MHz): δ11.5 (s, 1H), 8.49 (s, 1H), 8.29 (s, 1H) 7.82 (s, 1H) 6.20 (t, 1H, J= 
6.4 Hz), 5.25 (d, 1H, J= 4.4 Hz), 5.20 (s, 1H), J= 4.8 Hz), 4.27 (m, 1H), 3.83 (q, 1H, J= 3.6 
Hz), 3.72-3.58 (m, 2H), 2.23 (m, 1H), 2.12 (m, 1H); MALDI-MS [MH+] calcd. for 
C12H15N5O5, 332.0971; found, 332.0965. 
5'-O-(4,4'-Dimethoxytriphenylmethyl)-5-(4-methylchromen-2-one-1,2,3-triazol-
1-yl)methyl-2’-deoxyuridine (5c). Compound 5 (0.198 g, 0.64 mmol) was co-evaporated 
with anhydrous pyridine (3×5 mL) and then dissolved in pyridine (5 mL). To the solution, 
DMTCl (0.304 g, 0.90 mmol) was added in two portions and the reaction mixture was 
stirred at r.t. for 5 h. The reaction was quenched by addition of MeOH and was 
concentrated in vacuum. The crude product was purified by flash chromatography 
(CH2Cl2/MeOH/Et3N = 96/3/1) to give 5c (0.267 g, 68%) as off-white solid. 
1H NMR 
(CDCl3, 300 MHz): δ11.5 (s, 1H), 8.19 (s, 1H), 7.89 (s, 1H),7.82 (s, 1H), 7.67-7.31 (m, 14H), 
6.20 (t, 1H, J= 6.4 Hz),5.19 (t, 1H, J= 4.8 Hz), 4.27 (m, 1H), 3.83 (q, 1H, J= 3.6 Hz), 3.72-
3.58 (m, 2H), 3.5 (s,s, 6H), 2.23 (m, 1H), 2.12 (m, 1H):13C NMR (300 MHz, CDCl3):δ 162.4, 
158.3, 150.8, 148, 146.6, 141.4, 135.2, 131.4, 130.4, 130.14, 130.12, 130.04, 129.9, 
129.8, 129.19, 129.09, 129.01, 125.4, 121.4, 112, 108.4, 87.3, 86, 85.4, 78.3, 72.7, 65, 
98 
 
 
62.5, 55.8, 45.2, 44.1, 41, 35.2, 31.1, 29.3, 26, 22.1, 19.6, 13.4. MALDI-MS [MNa+] calcd. 
for C33H33N5O7, 634.2278; found, 634.2278. 
5'-O-(4,4'-Dimethoxytriphenylmethyl)-5-(4-methylchromen-2-one-1,2,3-triazol-
1-yl)methyl-2’-deoxyuridine-3'-(2-cyanoethyl)-N,N-diisopropylphosphoramidite (5d). 
Compound 5c (0.153 g, 0.25 mmol) was dissolved in anhydrous CH2Cl2 (5 mL) under Ar 
atmosphere. Diisopropylethylamine (96 μL, 0.55 mmol) and 2-cyanoethyl-N,N-
diisopropylchlorophosphoramidite (96 μL, 0.43 mmol) were added. The reaction mixture 
was stirred at r.t. for 30 min, diluted with CH2Cl2 (30 mL), washed with 5% aqueous 
NaHCO3 solution, followed by brine. The organic solution was dried over anhydrous 
Na2SO4, filtered, and concentrated. The residue was submitted to flash chromatography 
(EtOAc/CH2Cl2/Et3N = 66/33/1) to yield product 5d (0.157 g, 77%) as a white foam. 
31P 
NMR (CDCl3, 300 MHz): δ 150.0, 150.2. 
5-(4-Phenyl-1,2,3-triazol-1-yl)methyl-2’-deoxyuridine (6). To a solution of 
phenylacetylene (110 mg, 1.08 mmol) and 5-azido-methyl-2’-deoxyuridine (2) (270 mg, 
0.954 mmol) in MeOH (8 mL), a 0.296 M aqueous solution of Na-ascorbate (6 mL) was 
added, followed by a 0.368 M aqueous solution of Cu2SO4 (3.6 mL). After one hour, TLC 
confirmed completion of the reaction. The reaction mixture was evaporated to dryness 
and subjected to flash chromatography (DCM/MeOH, 20:1-7:1) yielding compound 6 
(273 mg, 74%) as a white foam. 1H NMR (DMSO-d6, 300 MHz): δ11.5 (s, 1H), 8.49 (s, 1H), 
8.29 (s, 1H)7.82 (s, 1H) 7.47-7.31 (m, 5H) 6.20 (t, 1H, J= 6.4 Hz), 5.25 (d, 1H, J= 4.4 
Hz),5.19 (t, 1H, J= 4.8 Hz), 4.27 (m, 1H), 3.83 (q, 1H, J= 3.6 Hz), 3.72-3.58 (m, 2H), 2.23 
(m, 1H), 2.12 (m, 1H):13C NMR (300 MHz, DMSO-d6):δ 162.4, 152.8, 146.6, 141.4, 132.4, 
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129.9, 129.1, 125.4, 121.4, 109, 88.4, 87.3, 85.4, 71.7, 60.8, 49.2, 47.1; MALDI-MS [MH+] 
calcd. for C22H21N5O7, 386.1519; found, 386.1515. 
5'-O-(4,4'-Dimethoxytriphenylmethyl)-5-(4-Phenyl-1,2,3-triazol-1-yl)methyl-2’-
deoxyuridine (6c). Compound 6 (0.246 g, 0.64 mmol) was co-evaporated with 
anhydrous pyridine (3×5 mL) and then dissolved in pyridine (5 mL). To the solution, 
DMTCl (0.304 g, 0.90 mmol) was added in two portions and the reaction mixture was 
stirred at r.t. for 5 h. The reaction was quenched by addition of MeOH and was 
concentrated in vacuo. The crude product was purified by flash chromatography 
(CH2Cl2/MeOH/Et3N = 10/5/1) to give 6c (0.3 g, 68%) as an off-white solid. 
1H NMR 
(CDCl3, 300 MHz): δ11.5 (s, 1H), 8.19 (s, 1H), 7.89 (s, 1H),7.82 (s, 1H), 7.67-7.31 (m, 18H), 
6.20 (t, 1H, J= 6.4 Hz),5.19 (t, 1H, J= 4.8 Hz), 4.27 (m, 1H), 3.83 (q, 1H, J= 3.6 Hz), 3.72-
3.58 (m, 2H), 3.5 (s,s, 6H), 2.23 (m, 1H), 2.12 (m, 1H):13C NMR (300 MHz, CDCl3):δ 162.4, 
158.3, 150.8, 148, 146.6, 141.4, 135.2, 131.4, 130.4, 130.14, 130.12, 130.04, 129.9, 
129.8, 129.19, 129.09, 129.01, 125.4, 121.4, 112, 108.4, 87.3, 86, 85.4, 78.3, 72.7, 65, 
62.5, 55.8, 45.2, 44.1, 41, 35.2, 31.1, 29.3, 26, 22.1, 19.6, 13.4. 
5'-O-(4,4'-Dimethoxytriphenylmethyl)-5-(4-Phenyl-1,2,3-triazol-1-yl)methyl-2’-
deoxyuridine-3'-(2-cyanoethyl)-N,N-diisopropylphosphoramidite (6d). Compound 6c 
(0.172 g, 0.25 mmol) was dissolved in anhydrous CH2Cl2 (5 mL) under Ar atmosphere. 
Diisopropylethylamine (96 μL, 0.55 mmol) and 2-cyanoethyl-N,N-
diisopropylchlorophosphoramidite (96 μL, 0.43 mmol) were added. The reaction mixture 
was stirred at r.t. for 30 min, diluted with CH2Cl2 (30 mL), washed with 5% aqueous 
NaHCO3 solution, followed by brine. The organic solution was dried over anhydrous 
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Na2SO4, filtered, and concentrated. The residue was submitted to flash chromatography 
(EtOAc/CH2Cl2/Et3N = 66/33/1) to yield product 6d (0.170 g, 78%) as a white foam. 
31P 
NMR (CDCl3, 300 MHz): δ 150.0, 150.2. 
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13C NMR (DMSO-d6, 300 MHz) of nucleoside 1 
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MS spectrum of nucleoside 1 
 
 
 
 
 
 
 
 
 
 
HN
O
N
1
N
O
O
HO
HO
O
O
N N
Cal. [MH+]: 468.1519
103 
 
 
ppm (t1)
0.05.0
0
50000000
100000000
150000000
 
1H-NMR (CDCl3, 300 MHz) of the DMT-protected nucleoside 4. 
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13C-NMR (CDCl3, 300 MHz) of the DMT-protected nucleoside 4 
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MS spectrum of compound 4 
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31P-NMR (CDCl3 300 MHz) of nucleoside 4a 
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MS spectrum of ODN-7a 
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MS spectrum of ODN-12a 
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MS spectrum of ODN-13a 
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MS spectrum of ODN-14a 
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MS spectrum of ODN-15a 
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1H-NMR (DMSO, 300 MHz) of the nucleoside 10a 
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1H-NMR (CDCL3, 300 MHz) of the nucleoside 10g 
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1H-NMR (CDCL3, 300 MHz) of the nucleoside 10h 
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1H-NMR (CDCL3, 300 MHz) of the nucleoside 10i 
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13C-NMR (CDCl3, 300 MHz) of the nucleoside 10i 
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Mass Analysis; 
ESI/APCI
 
MS spectrum of compound 10i: Cal; 446.17, Found; 446.17 
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1H-NMR (CDCL3, 300 MHz) of the nucleoside 10b 
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1H-NMR (CDCL3, 300 MHz) of the nucleoside 10c 
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1H-NMR (CDCL3, 300 MHz) of the nucleoside 10d 
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1H-NMR (DMSO, 300 MHz) of the nucleoside 10 
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13C-NMR (CDCl3, 300 MHz) of the nucleoside 10 
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1H-NMR (CDCL3, 300 MHz) of the nucleoside 11b 
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1H-NMR (CDCl3, 300 MHz) of the nucleoside 11c 
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13C-NMR (CDCl3, 300 MHz) of the nucleoside 11c 
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1H-NMR (DMSO, 300 MHz) of the nucleoside 11 
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MS spectrum of compound 11: Cal; 467.16, Found; 467.16 
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MS spectrum of 5 
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13C-NMR (CDCl3, 300 MHz) of the nucleoside 5c 
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MS spectrum of 5C 
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31P-NMR (CDCl3 300 MHz) of nucleoside 5d 
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MS spectrum of ODN-107: Calculated; 5071, Found; 5071 
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1H-NMR (DMSO, 300 MHz) of the nucleoside 6 
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MS spectrum of compound 6: Calculated; 386.15, Found; 386.15 
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